Trichostatin A (TSA)

For research use only. Not for use in humans.

目录号：S1045 中文名称：曲古柳菌素A

CAS No. 58880-19-6

Trichostatin A (TSA)是一种HDAC抑制剂，无细胞试验中IC50为1.8 nM左右。

规格

价格

库存

购买数量

2mg	RMB 2022.93	现货
5mg	RMB 5053.26	现货
10mg	RMB 10131.56	现货
大包装	有超大折扣

大剂量询单有大折扣!

今日订购，明日送达，全国免运费！

全国免费电话：400-668-6834 | Email：info@selleck.cn

客户使用Selleck生产的Trichostatin A (TSA)发表文献166篇：

Cell, 2019, 178(5):1115-1131

PubMed: 31442404 ( click the link to review the publication )

Cell Metab, 2019, 29(4):886-900

PubMed: 30661930 ( click the link to review the publication )

Nature, 2017, 551(7679):247-250

PubMed: 29088702 ( click the link to review the publication )

Cell, 2017, 171(4):824-835.e18

PubMed: 29056338 ( click the link to review the publication )

Nat Biotechnol, 2015, 10.1038/nbt.3130

PubMed: 25751058 ( click the link to review the publication )

Cancer Cell, 2014, 26(4):534-48

PubMed: 25314079 ( click the link to review the publication )

Cell Rep, 2021, 34(3):108646

PubMed: 33472062 ( click the link to review the publication )

Neoplasia, 2021, 23(1):129-139

PubMed: 33316537 ( click the link to review the publication )

Sci China Life Sci, 2021, 10.1007/s11427-020-1855-4

PubMed: 33420926 ( click the link to review the publication )

Nat Metab, 2021, 3(1):75-89

PubMed: 33462516 ( click the link to review the publication )

Autophagy, 2020, 10.1080/15548627.2019.1709762

PubMed: 31986961 ( click the link to review the publication )

Autophagy, 2020, 15:1-13

PubMed: 32264736 ( click the link to review the publication )

Theranostics, 2020, 10(21):9644-9662

PubMed: 32863951 ( click the link to review the publication )

Theranostics, 2020, 10(15):6790-6805

PubMed: 32550904 ( click the link to review the publication )

Cell Rep, 2020, 33(11):108507

PubMed: 33326790 ( click the link to review the publication )

mBio, 2020, 11(5)e02343-20

PubMed: 33024042 ( click the link to review the publication )

Free Radic Biol Med, 2020, 10.1016/j.freeradbiomed.2020.01.016

PubMed: 31972340 ( click the link to review the publication )

Cell Death Dis, 2020, 11(9):765

PubMed: 32943605 ( click the link to review the publication )

Signal Transduct Target Ther, 2020, 13;5(1):53

PubMed: 32398667 ( click the link to review the publication )

Cells, 2020, 21;9(5):E1280

PubMed: 32455774 ( click the link to review the publication )

Front Immunol, 2020, 3;11:36

PubMed: 32117228 ( click the link to review the publication )

Mol Cancer Ther, 2020, molcanther.0417.2020

PubMed: 33277442 ( click the link to review the publication )

Mol Neurobiol, 2020, 10.1007/s12035-019-01812-5

PubMed: 31919777 ( click the link to review the publication )

Am J Cancer Res, 2020, 10(2):523-535

PubMed: 32195024 ( click the link to review the publication )
Oncogenesis, 2020, 13;9(5):48

PubMed: 32404892 ( click the link to review the publication )

Mol Cancer Res, 2020, 10.1158/1541-7786.MCR-19-0669

PubMed: 32238439 ( click the link to review the publication )

Cancer Biol Med, 2020, 17(4):953-969

PubMed: 33299646 ( click the link to review the publication )

Immunol Cell Biol, 2020, 98(4):318-331

PubMed: 31950542 ( click the link to review the publication )

Front Chem, 2020, 23;8:184

PubMed: 32266211 ( click the link to review the publication )

J Immunol Res, 2020, 2020:7263602

PubMed: 33062724 ( click the link to review the publication )

BMC Microbiol, 2020, 20(1):28

PubMed: 32028887 ( click the link to review the publication )

Arch Insect Biochem Physiol, 2020, 103(4):e21649

PubMed: 31777104 ( click the link to review the publication )

Cell Rep, 2020, 30(7):2195-2208

PubMed: 32075759 ( click the link to review the publication )

Theranostics, 2020, 10(17):7747-7757

PubMed: 32685017 ( click the link to review the publication )

Theranostics, 2020, 10(5):2188-2200

PubMed: 32104503 ( click the link to review the publication )

Mol Cell, 2019, 73(4):788-802

PubMed: 30704899 ( click the link to review the publication )

Mol Cell, 2019, 74(6):1250-1263

PubMed: 31054974 ( click the link to review the publication )

Nat Commun, 2019, 10(1):5792

PubMed: 31857589 ( click the link to review the publication )

Nat Commun, 2019, 10(1):4353

PubMed: 31554795 ( click the link to review the publication )

Nat Commun, 2019, 10(1):5800

PubMed: 31863007 ( click the link to review the publication )

Nucleic Acids Res, 2019, 19;47(16):8502-8520

PubMed: 31616951 ( click the link to review the publication )

Autophagy, 2019, 1-13

PubMed: 30957628 ( click the link to review the publication )

Autophagy, 2019, 10.1080/15548627.2019.1707488

PubMed: 31878840 ( click the link to review the publication )

PLoS Biol, 2019, 17(10):e3000461

PubMed: 31600191 ( click the link to review the publication )

Cancer Res, 2019, 10.1158/0008-5472.CAN-18-2486

PubMed: 31253668 ( click the link to review the publication )

J Cell Biol, 2019, 218(1):267-284

PubMed: 30538141 ( click the link to review the publication )

J Cell Biol, 2019, 218(12):4017-4029

PubMed: 31645458 ( click the link to review the publication )

Cell Death Differ, 2019, 26(5):843-859

PubMed: 29988076 ( click the link to review the publication )
Int J Cancer, 2019, 10.1002/ijc.32425

PubMed: 31111958 ( click the link to review the publication )

Mol Ther, 2019, 27(5):1039-1050

PubMed: 30852137 ( click the link to review the publication )

EBioMedicine, 2019, 43:238-252

PubMed: 31047858 ( click the link to review the publication )

J Bone Miner Res, 2019, 10.1002/jbmr.3716

PubMed: 31112333 ( click the link to review the publication )

J Exp Clin Cancer Res, 2019, 38(1):428

PubMed: 31665064 ( click the link to review the publication )

J Exp Clin Cancer Res, 2019, 38(1):84

PubMed: 30777099 ( click the link to review the publication )

J Exp Clin Cancer Res, 2019, 38(1):463

PubMed: 31718704 ( click the link to review the publication )

J Mol Cell Biol, 2019, 10.1093/jmcb/mjz093

PubMed: 31560394 ( click the link to review the publication )

Mol Cancer Ther, 2019, 18(5):900-908

PubMed: 30824609 ( click the link to review the publication )

Mol Neurobiol, 2019, 10.1007/s12035-019-1565-7

PubMed: 30963442 ( click the link to review the publication )

J Mol Med (Berl), 2019, 97(4):541-552

PubMed: 30806715 ( click the link to review the publication )

Pharmacol Res, 2019, 146:104281

PubMed: 31125601 ( click the link to review the publication )

Cancer Sci, 2019, 110(11):3442-3452

PubMed: 31432592 ( click the link to review the publication )

J Neurochem, 2019, 10.1111/jnc.14935

PubMed: 31811660 ( click the link to review the publication )

J Virol, 2019, 93(4)e01896-18

PubMed: 30518648 ( click the link to review the publication )

Front Cell Neurosci, 2019, 13:468

PubMed: 31708743 ( click the link to review the publication )

Sci Rep, 2019, 9(1):1897

PubMed: 30760778 ( click the link to review the publication )

Sci Rep, 2019, 9(1):4360

PubMed: 30867438 ( click the link to review the publication )

PLoS Comput Biol, 2019, 15(2):e1006826

PubMed: 30785874 ( click the link to review the publication )

Front Genet, 2019, 10:422

PubMed: 31130994 ( click the link to review the publication )

Life Sci, 2019, 223:1-8

PubMed: 30862568 ( click the link to review the publication )

J Cell Biochem, 2019, 10.1002/jcb.29470

PubMed: 31692090 ( click the link to review the publication )

Cell Adh Migr, 2019, 13(1):285-292

PubMed: 31271097 ( click the link to review the publication )

Alcohol Clin Exp Res, 2019, 43(5):822-832

PubMed: 30860602 ( click the link to review the publication )
Oncol Rep, 2019, 41(6):3209-3218

PubMed: 31002353 ( click the link to review the publication )

Int J Mol Med, 2019, 44(5):1789-1800

PubMed: 31545402 ( click the link to review the publication )

Int J Mol Med, 2019, 43(1):285-293

PubMed: 30387821 ( click the link to review the publication )

Tuberculosis (Edinb), 2019, 118:101861

PubMed: 31526947 ( click the link to review the publication )

ACS Omega, 2019, 4(22):19895-19904

PubMed: 31788622 ( click the link to review the publication )

Reprod Fertil Dev, 2019, 31(3):473-481

PubMed: 30301509 ( click the link to review the publication )

Res Vet Sci, 2019, 126:207-212

PubMed: 31610471 ( click the link to review the publication )

Exp Ther Med, 2019, 17(6):4547-4553

PubMed: 31186678 ( click the link to review the publication )

Sci Adv, 2019, 5(3):eaav1118

PubMed: 30944854 ( click the link to review the publication )

Nat Biomed Eng, 2018, 2(8):578-588

PubMed: 31015631 ( click the link to review the publication )

J Clin Invest, 2018, 128(9):4098-4114

PubMed: 30124467 ( click the link to review the publication )

Cell Rep, 2018, 24(7):1722-1729

PubMed: 30110629 ( click the link to review the publication )

Mol Ther, 2018, 26(7):1828-1839

PubMed: 29730197 ( click the link to review the publication )

Oncogene, 2018, 37(50):6414-6424

PubMed: 30068939 ( click the link to review the publication )

Cancer Lett, 2018, 432:121-131

PubMed: 29890207 ( click the link to review the publication )

Mol Oncol, 2018, 12(5):724-755

PubMed: 29577611 ( click the link to review the publication )

Oncogenesis, 2018, 7(11):91

PubMed: 30467308 ( click the link to review the publication )

J Proteome Res, 2018, 17(4):1436-1451

PubMed: 29564889 ( click the link to review the publication )

Plant Cell Rep, 2018, 37(1):115-123

PubMed: 28939922 ( click the link to review the publication )

Exp Cell Res, 2018, 371(1):231-237

PubMed: 30107147 ( click the link to review the publication )

Int Immunopharmacol, 2018, 65:303-311

PubMed: 30342347 ( click the link to review the publication )

Oncol Rep, 2018, 39(4):1892-1900

PubMed: 29393444 ( click the link to review the publication )

Biochem Biophys Res Commun, 2018, 503(2):420-427

PubMed: 29649477 ( click the link to review the publication )

Cell Biochem Funct, 2018, 36(8):398-407

PubMed: 30484863 ( click the link to review the publication )
Med Sci Monit, 2018, 24:461-472

PubMed: 29363667 ( click the link to review the publication )

Methods Mol Biol, 2018, 1755:179-195

PubMed: 29671271 ( click the link to review the publication )

Curr Protoc Pharmacol, 2018, 81(1):e41

PubMed: 29927058 ( click the link to review the publication )

Sci Rep, 2018, 8(1):13072

PubMed: 30166563 ( click the link to review the publication )

Cell Res, 2017, 27(7):898-915

PubMed: 28497810 ( click the link to review the publication )

Mol Cell, 2017, 67(4):566-578

PubMed: 28803781 ( click the link to review the publication )

Cell Mol Immunol, 2017, 14(4):371-379

PubMed: 26388239 ( click the link to review the publication )

Oncogene, 2017, 36(12):1707-1720

PubMed: 27694895 ( click the link to review the publication )

Chemistry, 2017, 23(13):3107-3116

PubMed: 27922200 ( click the link to review the publication )

Cancer Epidemiol Biomarkers Prev, 2017, 26(9):1411-1419

PubMed: 28619831 ( click the link to review the publication )

Eur J Med Chem, 2017, 127:531-553

PubMed: 28109947 ( click the link to review the publication )

J Biol Chem, 2017, 292(31):12842-12859

PubMed: 28634230 ( click the link to review the publication )

J Pharmacol Exp Ther, 2017, 363(2):211-220

PubMed: 28860353 ( click the link to review the publication )

J Diabetes Res, 2017, 2017:8208065

PubMed: 28191472 ( click the link to review the publication )

Int J Parasitol Drugs Drug Resist, 2017, 7(1):51-60

PubMed: 28110187 ( click the link to review the publication )

PLoS One, 2017, 12(10):e0186620

PubMed: 29045501 ( click the link to review the publication )

Connect Tissue Res, 2017, 58(1):64-75

PubMed: 27404795 ( click the link to review the publication )

Biochem Biophys Res Commun, 2017, 485(2):454-460

PubMed: 28192116 ( click the link to review the publication )

Oncotarget, 2017, 8(11):17995-18009

PubMed: 28152508 ( click the link to review the publication )

Oncotarget, 2017, 8(7):11937-11949

PubMed: 28060760 ( click the link to review the publication )

Bioorg Med Chem, 2017, 25(7):2105-2132

PubMed: 28259528 ( click the link to review the publication )

Nat Commun, 2016, 7:10690

PubMed: 26891683 ( click the link to review the publication )

Nucleic Acids Res, 2016, 45(3):1159-1176

PubMed: 28180300 ( click the link to review the publication )

Clin Cancer Res, 2016, 22(8):1978-88

PubMed: 26634271 ( click the link to review the publication )
Thorax, 2016, 633-45

PubMed: 27071418 ( click the link to review the publication )

EMBO Rep, 2016, 17(7):999-1012

PubMed: 27154402 ( click the link to review the publication )

J Med Chem, 2016, 59(4):1613-33

PubMed: 26681404 ( click the link to review the publication )

PLoS Pathog, 2016, 12(10):e1005950

PubMed: 27764245 ( click the link to review the publication )

Free Radic Biol Med, 2016, 99:167-178

PubMed: 27498117 ( click the link to review the publication )

Oxid Med Cell Longev, 2016, 2016:4085727

PubMed: 27746856 ( click the link to review the publication )

FEBS J, 2016, 283(20):3739-3754

PubMed: 27573079 ( click the link to review the publication )

Am J Pathol, 2016, 186(10):2701-8

PubMed: 27555113 ( click the link to review the publication )

Mol Cell Biol, 2016, 36(22):2838-2854

PubMed: 27573019 ( click the link to review the publication )

Int J Oncol, 2016, 48(6):2591-607

PubMed: 27082124 ( click the link to review the publication )

BMC Cancer, 2016, 16(1):886

PubMed: 27842508 ( click the link to review the publication )

Mol Cell Biochem, 2016, 415(1-2):197-205

PubMed: 27000860 ( click the link to review the publication )

Oncotarget, 2016, 8(60):100975-100988

PubMed: 29254139 ( click the link to review the publication )

Genet Mol Res, 2016, 15(4)

PubMed: 27819724 ( click the link to review the publication )

Sci Rep, 2016, 6:21678

PubMed: 26902929 ( click the link to review the publication )

Tumour Biol, 2016, 37(6):8293-304

PubMed: 26729194 ( click the link to review the publication )

Tumour Biol, 2016, 37(8):10269-78

PubMed: 26831669 ( click the link to review the publication )

Nat Commun, 2015, 3;6:10091

PubMed: 26631872 ( click the link to review the publication )

EMBO Mol Med, 2015, 10.15252/emmm.201404396

PubMed: 25872941 ( click the link to review the publication )

Cancer Lett, 2015, 356(2 Pt B):828-36

PubMed: 25449774 ( click the link to review the publication )

Am J Transplant, 2015, 10.1111/ajt.13106

PubMed: 25708614 ( click the link to review the publication )

Cell Death Dis, 2015, 6:e1586

PubMed: 25569103 ( click the link to review the publication )

J Antimicrob Chemother, 2015, 10.1093/jac/dku549

PubMed: 25558076 ( click the link to review the publication )

Mol Nutr Food Res, 2015, 59(2):189-202

PubMed: 25303559 ( click the link to review the publication )
Mol Nutr Food Res, 2015, 59(2):189-202

PubMed: ( click the link to review the publication )

Am J Physiol Lung Cell Mol Physiol, 2015, 309(12):L1410-9

PubMed: 26498249 ( click the link to review the publication )

Chem Biol Interact, 2015, 242:227-34

PubMed: 26482938 ( click the link to review the publication )

PLoS One, 2015, 10(3):e0120587

PubMed: 25807249 ( click the link to review the publication )

Oncotarget, 2015, 6(18):15814-27

PubMed: 26158412 ( click the link to review the publication )

EMBO J, 2014, 34(1):115-29

PubMed: 25398909 ( click the link to review the publication )

Proc Natl Acad Sci USA, 2014, 111(3):E364-73

PubMed: 24395801 ( click the link to review the publication )

PLoS Biol, 2014, 12(1):e1001758

PubMed: 24409098 ( click the link to review the publication )

Cancer Lett, 2014, 10.1016/j.canlet.2014.10.034

PubMed: ( click the link to review the publication )

Mol Cell Biol, 2014, 34(22):4143-64

PubMed: 25202123 ( click the link to review the publication )

Toxicol Appl Pharmacol, 2014, 274(1):7-16

PubMed: 24200994 ( click the link to review the publication )

Life Sci, 2014, 99(1-2):31-6

PubMed: 24486299 ( click the link to review the publication )

Biochem Biophys Res Commun, 2014, 445(2):320-6

PubMed: 24530917 ( click the link to review the publication )

Exp Hematol, 2014, 42(7):574-80

PubMed: 24607957 ( click the link to review the publication )

Sci Rep, 2014, 4:4663

PubMed: 24722541 ( click the link to review the publication )

Science, 2014, 344(6183):1252304

PubMed: 24727982 ( click the link to review the publication )

Neuropsychopharmacology, 2013, 38(9):1674-84

PubMed: 23474591 ( click the link to review the publication )

Plant J, 2013, 74(5):815-28

PubMed: 23464703 ( click the link to review the publication )

Cytokine, 2013, 65(2):121-5

PubMed: 24373940 ( click the link to review the publication )

Genes Brain Behav, 2013, 13(1):69-86

PubMed: 24286462 ( click the link to review the publication )

Epigenetics, 2012, 7(10):1161-72

PubMed: 22965008 ( click the link to review the publication )

Adv Genet, 2010, 70:341-86

PubMed: 20920755 ( click the link to review the publication )

产品安全说明书

HDAC抑制剂选择性比较

生物活性

产品描述

Trichostatin A (TSA)是一种HDAC抑制剂，无细胞试验中IC50为1.8 nM左右。

靶点

HDAC ^[1]
(Cell-free assay)

~1.8 nM

体外研究

Trichostatin A 抑制八种乳腺癌细胞系，包括MCF-7, T-47D, ZR-75-1, BT-474, MDA-MB-231, MDA-MB-453, CAL 51, 和 SK-BR-3增殖，平均IC50为124.4 nM (范围为26.4-308.1 nM),作用于表达ERα的细胞系比作用于表达 ERα阴性的细胞系更有效。Trichostatin A作用于全部乳腺癌细胞系，抑制HDAC活性，平均IC50为 2.4 nM (范围为0.6-2.6 nM), 产生显著的组蛋白 H4高度乙酰化。^[1]与 Trapoxin (TPX) 和 Chlamydocin 有效抑制HDAC1 或 HDAC4而不是 HDAC6不同，Trichostatin A 抑制这些HDACs，且抑制程度相似， IC50 分别为6 nM, 38 nM, 和8.6 nM。^[2] Trichostatin A (100 ng/mL) 作用于MIA PaCa-2细胞，通过招募p300和 PCAF进入Sp1-NF-Y HDAC复合体，而诱导转化生长因子βⅡ型受体(TβRII) 表达，复合体与TβRII 启动子的DNA片段结合，伴随着Sp1乙酰化，且与复合体相关的HDAC数理全部降低。^[4]

Cell Data

Cell Lines	Assay Type	Concentration	Incubation Time	Formulation	Activity Description	PMID
HeLa	NXrZTGJOT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MoTyNVAwOzBxNUCgcm0>	Mo\kO\|IhcA>?	NFTkXGZFVVOR	NYjidVF5cW6lcnXhd4V{KHSqZTDueY1j\XJib3[gUW1RKCkQlN8ocUkhdG:\|czDj[YxteyCmb4PlJIRmeGWwZHXueIx6	MYG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzF4NUe0PEc,OjNzNkW3OFg9N2F-
HeLa	NIH0fZRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NV64fJdUOjBibl2=	NXnTUW52PzJiaB?=	M{L6[mROW09?	NGX5bGhKSzVyIH;mJFIxdk1?	MlHqQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjNzNkW3OFgoRjJ\|MU[1O\|Q5RC:jPh?=
HeLa	NGX2R\|JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M3rteVQxKG6P	M3;0elQ5KGh?	M{LpcGROW09?	NFTmTohKSzVyIH;mJFQxdk1?	NWmyUIdoRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkOxOlU4PDhpPkKzNVY2PzR6PD;hQi=>
HeLa	MojES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NUjBUlIyOTByIH7N	NUG4VphlOjRiaB?=	NG[xbGlFVVOR	NX;MPJhYUUN3MDDv[kAyODCwTR?=	Mn3rQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjNzNkW3OFgoRjJ\|MU[1O\|Q5RC:jPh?=
Caco-2	NHi5OlRHfW6ldHnvckBCe3OjeR?=	MVSxJOK2VcLi	NYD4fJc3OjRiaB?=		NHPFR4hl\WO{ZXHz[ZMhW0WUVDDwdo91\WmwIHX4dJJme3Orb36=	MWK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzF7NUC3NEc,OjNzOUWwO\|A9N2F-
HTK	MkHySpVv[3Srb36gRZN{[Xl?	MVuxNFAuQDBybl2=	MUG3NkBp		NWex[G92[myxY3vzJHRITi4QsvMAl2lv\HWlZXSgVm9UKGGwZDDINm8zyqCDY3P1cZVt[XSrb36=	NFXwfZU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{K4OFAxOid-MkOyPFQxODJ:L3G+
HTK	NFr4SXNHfW6ldHnvckBCe3OjeR?=	NIW2[no1ODBibl2=	NIW5cog4OiCq		Mlj3bY5pcWKrdIOgWGdHNc7{4pETTY5lfWOnZDDNfY9ncWK{b3LsZZN1KESrZn\ldoVvfGmjdHnvci=>	MlyxQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN{OESwNFIoRjJ\|Mki0NFAzRC:jPh?=
HEK293	MV;GeY5kfGmxbjDBd5NigQ>?	NGLOSG0yKML3TdMg	MYexPEBpyqB?		MV3pcohq[mm2czD0bIUhc2GuaYLpck04NW2nZHnheIVlKHKnY4L1bZRu\W62IH;mJJN6dnCqaXzpck0yKGGpZ4Ll[4F1\XNiaX70c{Bi\2e{ZYPvcYV{	NILUSWo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{K4OFg1QCd-MkOyPFQ5PDh:L3G+
SH-SY5Y	NIH5dHBHfW6ldHnvckBCe3OjeR?=	M4SyZVI2OCCwTR?=	MXSxOkBp		NInhU4NkcGGwZ3XzJIV5eHKnc4Ppc44heGG2dHXyckBw\iCpZX7ld{Bqdn[xbI\l[EBqdiClaH;s[ZN1\XKxbDDzfY51cGW\|aYOsJJVxfGGtZTDhcoQh\W[obIX4	Mlr3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN\|Mk[0NlIoRjJ\|M{K2OFIzRC:jPh?=
THP1	MmHpRZBweHSxc3nzJGF{e2G7	MmT5NUDPxE1?	M3SxclI1KGh?		M{\MdYlv\HWlZYRCpINmdGxiZHXheIg>	M4OyUFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ\|NECwOVE6Lz5{M{SwNFUyQTxxYU6=
K562	MWHBdI9xfG:\|aYOgRZN{[Xl?	M4DFSFEh\|ryP	M1Kx[lI1KGh?		M2f0TIlv\HWlZYRCpINmdGxiZHXheIg>	MU[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzRyMEWxPUc,OjN2MEC1NVk9N2F-
Kazumi	NX;OV3ZJSXCxcITvd4l{KEG\|c3H5	MmXvNUDPxE1?	NHrHUpQzPCCq		MUnpcoR2[2W\|wrDj[YxtKGSnYYTo	NV3yTnN4RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO0NFA2OTlpPkKzOFAxPTF7PD;hQi=>
KG1	NIS0TVRCeG:ydH;zbZMhSXO\|YYm=	Mnz1NUDPxE1?	MnvUNlQhcA>?		MVHpcoR2[2W\|wrDj[YxtKGSnYYTo	NGHtW\|I9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{SwNFUyQSd-MkO0NFA2OTl:L3G+
HL60	MlzIRZBweHSxc3nzJGF{e2G7	NYC4bnJTOSEQvF2=	MkXJNlQhcA>?		NVmxSZFFcW6mdXPld:Kh[2WubDDk[YF1cA>?	NHrF[W09[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{SwNFUyQSd-MkO0NFA2OTl:L3G+
HEL	M2qy[GZ2dmO2aX;uJGF{e2G7	MnXTNE42KM7:TR?=	MmC2NlQhcA>?	NHHBXnVmfGijbn;s	MVvk[YNz\WG\|ZYOgeIhmKGWweont[UBi[3Srdnn0fUBw\iCKRFHDd{Bkdy22cnXheI1mdnRid3n0bEBkfXKldX3pci=>	NXP6O5VPRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO0N\|A6PTdpPkKzOFMxQTV5PD;hQi=>
K562	NYLJZ29TTnWwY4Tpc44hSXO\|YYm=	NXH4XFgyOC53IN88US=>	NYHndGNPOjRiaB?=	MWjleIhidm:u	Ml6y[IVkemWjc3XzJJRp\SCnbor5cYUh[WO2aY\peJkhd2ZiSFTBR5Mh[29vdILlZZRu\W62IIfpeIgh[3W{Y4XtbY4>	M1XZVVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ\|NEOwPVU4Lz5{M{SzNFk2PzxxYU6=
LM8	NGjYeZNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NELRTVQxNjNizszN	MlrmNVIuQTZiaB?=	NWq0UZo4TE2VTx?=	M{jvN4lvcGmkaYTzJJRp\SClZXzsJIdzd3e2aDDjc{11emWjdH3lcpQhf2m2aDDt[ZRnd3KvaX6=	MUG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzR3MUixO{c,OjN2NUG4NVc9N2F-
MG-63	NXzicYFHT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NHfsc3cxNjNizszN	MY[xNk06PiCq	M1vuRWROW09?	NX7KR5V2cW6qaXLpeJMhfGinIHPlcIwh\3Kxd4ToJINwNXS{ZXH0cYVvfCC5aYToJI1mfG[xcn3pci=>	NEm1ZWU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{S1NVgyPyd-MkO0OVE5OTd:L3G+
H1299	MmDMSpVv[3Srb36gRZN{[Xl?	NXOzUlQxOC53IN88US=>	MWO0PEBp	M1ewcWROW09?	Mn3RbY5pcWKrdIOgeIhmKGmwdnHzbZZmdmW\|c9MgJINwdWKrbnWge4l1cCC\|aXzpZolvcW5?	MlH3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN2NkG5O\|UoRjJ\|NE[xPVc2RC:jPh?=
H1299	NHvr[ZFHfW6ldHnvckBCe3OjeR?=	MYOwMlUh\|ryP	MX60PEBp	MmX5SG1UVw>?	M4W3PIlvcGmkaYTzJJRp\SCvaXfyZZRwenlicH;0[Y51cWGuIHPvcYJqdmVid3n0bEB{cWyrYnnubY4>	MnTWQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN2NkG5O\|UoRjJ\|NE[xPVc2RC:jPh?=
H1299	NETCSotHfW6ldHnvckBCe3OjeR?=	M3rZdlAvOzQkgKOxxsDDvU1?	M4S0N\|I1NzR6IHi=	M{DScmROW09?	M1P5XYlv[3KnYYPld{BGNWOjZHjldolvKHC{b4TlbY4hdGW4ZXzzJIRwe2ViZHXw[Y5l\W62bIm=	MVK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzR4MUm3OUc,OjN2NkG5O\|U9N2F-
MCF7	NVXRfFhPTnWwY4Tpc44hSXO\|YYm=	MoXZNE4xPS1{IN88US=>	Ml;LNlQhcA>?		MVTy[YR2[2W\|IITo[UBqdmS3Y4Tpc44hd2ZicEWzMYRmeGWwZHXueEBo\W6nczDifUBPfXSuaX6tNy=>	NVjBSZVERGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO0O\|A2PDBpPkKzOFcxPTRyPD;hQi=>
ARN8	M4LGOmZ2dmO2aX;uJGF{e2G7	M2TIUlAvODVvMjFOwG0>	M2jxdlI1KGh?		MmDzdoVlfWOnczD0bIUhcW6mdXP0bY9vKG:oIIC1N{1l\XCnbnTlcpQh\2WwZYOgZpkhVnW2bHnuMVM>	MknSQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN2N{C1OFAoRjJ\|NEewOVQxRC:jPh?=
U373	NF:2UIJHfW6ldHnvckBCe3OjeR?=	M2HxOlAvOjVxMD61M\|Eh\|ryP	MYSyOEBp		NXu0elBocW6lcnXhd4V{KFCULVKg[ZhxemW\|c3nvckBkdy22cnXheI1mdnRid3n0bEA2SXqjZFO=	M2TFdFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ\|NEe0NVcyLz5{M{S3OFE4OTxxYU6=
HASMCs	NE\qRZZHfW6ldHnvckBCe3OjeR?=	M3fOd\|AuPTByIH7N	NX;3RZdpPiCm		NIftdYdld3ewLYLl[5Vt[XSnczD0bIUh\XiycnXzd4lwdiCxZjDIRWREKGGwZDDj[YxtKH[rYXLpcIl1gQ>?	Mlf2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN3MUi0OlcoRjJ\|NUG4OFY4RC:jPh?=
MFE296	NGjG[nBHfW6ldHnvckBCe3OjeR?=	MUS1NFAhdk1?	NFnjTVA2KGR?	M{PRXWROW09?	MXXpcoR2[2W\|IFyxR2FOyqCneIDy[ZN{cW:wIHPvMZRz\WG2bXXueEB4cXSqIEWtRZpiSw>?	NWniOnJKRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO1N\|A4PjlpPkKzOVMxPzZ7PD;hQi=>
EN1	M1:4cWZ2dmO2aX;uJGF{e2G7	NV;2eIJWPTByIH7N	NUCyOHV2PSCm	M1XtZ2ROW09?	MkLHbY5lfWOnczDMNWNCVcLiZYjwdoV{e2mxbjDjc{11emWjdH3lcpQhf2m2aDC1MWF7[UN?	Mne2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN3M{C3OlkoRjJ\|NUOwO\|Y6RC:jPh?=
HEC1A	MWTGeY5kfGmxbjDBd5NigQ>?	MlfIOVAxKG6P	M{H6eVUh\A>?	MmnhSG1UVw>?	NYjlTFl1cW6mdXPld{BNOUODTdMg[ZhxemW\|c3nvckBkdy22cnXheI1mdnRid3n0bEA2NUG8YVO=	MnfTQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN3M{C3OlkoRjJ\|NUOwO\|Y6RC:jPh?=
ECC1	Mn70SpVv[3Srb36gRZN{[Xl?	Mkf6OVAxKG6P	NYD0V4xnPSCm	MneySG1UVw>?	MY\pcoR2[2W\|IFyxR2FOyqCneIDy[ZN{cW:wIHPvMZRz\WG2bXXueEB4cXSqIEWtRZpiSw>?	M1;EOlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ\|NUOwO\|Y6Lz5{M{WzNFc3QTxxYU6=
AGS	NGDE[nNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NYfybldpOC5yMUWtNUDPxE1?	MVy3NkBp		M33GWolv\HWlZYOgZ4VtdCCmZXH0bEBkd26lZX70doF1cW:wIHTldIVv\GWwdHz5	MkjOQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN5NEWwNlQoRjJ\|N{S1NFI1RC:jPh?=
Huh7	MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M3nFZlEh\|ryP	MknUNlQhcA>?	MnjPSG1UVw>?	M3TIdJJm\HWlZYOgZYJwfXRiMkClJJZq[WKrbHn0feKh	Mon4QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN4NEO5N\|MoRjJ\|NkSzPVM{RC:jPh?=
Lovo	NHWwS5FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NGHnZXgxNjJxMT6wM\|UvOCEQvF2=	NGnlcm8yOi9{ND:zOk81QCCq		Mn;UbY5lfWOnczDj[YxtKGSnYYToJIlvKGOxbnPlcpRz[XSrb36tJIFv\CC2aX3lMYRmeGWwZHXueEBu[W6wZYK=	NYHSXXJZRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO3O\|AxODBpPkKzO\|cxODByPD;hQi=>
HCT1	MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MVywMlIwOS5yL{WuNEDPxE1?	M2jDRVEzNzJ2L{O2M\|Q5KGh?		NWnCS5hpcW6mdXPld{Bk\WyuIHTlZZRpKGmwIHPvcoNmdnS{YYTpc44uKGGwZDD0bY1mNWSncHXu[IVvfCCvYX7u[ZI>	M{HuelxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ\|N{ewNFAxLz5{M{e3NFAxODxxYU6=
SUM190PT	MlSwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NXv0cGlxPTBxMUCwM\|I2OCCwTR?=	Mke1OFghcA>?	M4DZZmROW09?	NFjESJJqdmS3Y3XzJINmdGxiZHXheIgh[XRiNUCgcm0he2Wwc3n0bZZmdHl?	M{Pnd\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ\|N{myOlM5Lz5{M{e5NlY{QDxxYU6=
SUM149PT	NYHoVVBET3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NXH2e4EyOi95LkWvNVAh\|ryP	MW[0PEBp	NUixPJJYTE2VTx?=	NYDzS\|N3cW6mdXPld{Bk\WyuIHTlZZRpKGG2IEKg{txOKGmwc3Xud4l1cX[nbIm=	NUfTTppXRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO3PVI3OzhpPkKzO\|kzPjN6PD;hQi=>
H1299	NVvRV2F3SXCxcITvd4l{KEG\|c3H5	NEXMVowxNjVxMTFOwG0>	MXu0PEBp	MWnleIhidm:u	NUK4WlhIcW6mdXPld{Bk\WyuIHHwc5B1d3Orcx?=	Ml;FQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN6Nke5PVEoRjJ\|OE[3PVkyRC:jPh?=
A549	Ml\rRZBweHSxc3nzJGF{e2G7	NV\FRmVwOC53L{Gg{txO	NWfTbXA5PDhiaB?=	M4K5VIV1cGGwb3y=	NIDOZnNqdmS3Y3XzJINmdGxiYYDvdJRwe2m\|	NHfQbYk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{i2O\|k6OSd-MkO4Olc6QTF:L3G+
H1299	M3vXXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MnL6NE4zPS9yLkWvNUDPxE1?	MmTRNlQwPDhxN{KgbC=>	MX;leIhidm:u	NFT0PZhqdmirYnn0d{B1cGViY3XscEBoem:5dHigbY4h[2:wY3XueJJifGmxbjDhcoQhfGmvZT3k[ZBmdmSnboSgcYFvdmW{	MYe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzh4N{m5NUc,OjN6Nke5PVE9N2F-
A549	Mn\PS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NHzCTGYxNjJ3L{CuOU8yKM7:TR?=	MY[yOE81QC95MjDo	MXLleIhidm:u	M1eycIlvcGmkaYTzJJRp\SClZXzsJIdzd3e2aDDpckBkd26lZX70doF1cW:wIHHu[EB1cW2nLXTldIVv\GWwdDDtZY5v\XJ?	MnLIQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN6Nke5PVEoRjJ\|OE[3PVkyRC:jPh?=
H1299	M2P2Smdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NGL2eI0yyqEQvF5CpC=>	NVzrSXNqOjRxNEivO\|IhcA>?	NFrvS5dmfGijbn;s	NYfDWYI{cW6lcnXhd4V{KGOnbHyg[IVifGhiYX\0[ZIhOjSq	NEjle2M9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{mxOlYxQSd-MkO5NVY3ODl:L3G+
PMNs	MWDGeY5kfGmxbjDBd5NigQ>?	MXmzNEBvVQ>?	NHTlPIs1QCCq		MWXpcohq[mm2czDl[oZmem:leYTvd4l{NCCKRFHDJIFkfGm4aYT5JIFv\CCUYXOgZYN1cX[rdIm=	NHS0Znk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{m4PFYyPyd-MkO5PFg3OTd:L3G+
CA46	NUH5e2lDT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NXLYbJpJOy94L{GyM\|I1NzR6IH7N	MX60PEBp		MYjpcohq[mm2czD0bIUh[2WubDDwdo9tcW[ncnH0bY9vKGG2IEK0JIFv\CB2ODDuUeKh	M1r0[FxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2ME[0PVUyLz5{NEC2OFk2OTxxYU6=
HCT116	M1faOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M4rCclAvOiEQvF2=	Mm\VNVIhcA>?		NYTPdJRR\W6qYX7j[ZMh[2WubDDhdI9xfG:\|aYOgbY5lfWOnZDDifUBz[WSrYYTpc44>	NGe3UYY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEGyNlI{OSd-MkSxNlIzOzF:L3G+
HLEB3	NETxd5ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M4nHdVAvPC9yLkig{txO	NFv1dmY1QCCq	MoLWSG1UVw>?	MYjpcoR2[2W\|IHPlcIwh[XCxcITvd4l{	NUKzZWdsRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkSxOVc5PzhpPkK0NVU4QDd6PD;hQi=>
SRA01/04	NWT6S5BqT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NInOOlQxNjRxMD64JO69VQ>?	MUe0PEBp	NXzBZWozTE2VTx?=	MlLjbY5lfWOnczDj[YxtKGGyb4D0c5Nqew>?	M1G5[VxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2MUW3PFc5Lz5{NEG1O\|g4QDxxYU6=
HLEB3	MnPYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MX2wMlIh\|ryP	MofWOFghcA>?	MXnEUXNQ	NH;HNG9{fXCycnXzd4V{KGOnbHygdJJwdGmoZYLheIlwdiC2aILveYdpKHO3cIDy[ZN{cW6pIITo[UBRUTONL1HreEwheDN6TVHQT{BidmRiRWLLNU8zKHOrZ37hcIlv\yCyYYToe4F6ew>?	NIDXW249[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEG1O\|g4QCd-MkSxOVc5Pzh:L3G+
SRA01/04	MoLBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MkTINE4zKM7:TR?=	M4jBVFQ5KGh?	NFXPWHhFVVOR	NVjnZY1ze3WycILld5NmeyClZXzsJJBzd2yrZnXyZZRqd25idHjyc5VocCC\|dYDwdoV{e2mwZzD0bIUhWEl\|Sz;Bb5QtKHB\|OF3BVGsh[W6mIFXST\|EwOiC\|aXfuZYxqdmdicHH0bJdigXN?	MUO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDF3N{i3PEc,OjRzNUe4O\|g9N2F-
A2780	Mk\2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MVOwMlA2NTJizszN	MlTPNVAwOjRxNEigbC=>	MUPEUXNQ	NVexN2pGdWWmaXH0[ZMh\3Kxd4ToJIFzemW\|dDDpckBiKGOxbnPlcpRz[XSrb36tJIFv\CC2aX3lMYRmeGWwZHXueEBu[W6wZYK=	NYjieHNNRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkSyNlM5ODFpPkK0NlI{QDBzPD;hQi=>
SKOV3	MoDRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M1fGNVAvODVvMjFOwG0>	MlrGNVAwOjRxNEigbC=>	MlrGSG1UVw>?	MVvt[YRq[XSnczDndo94fGhiYYLy[ZN1KGmwIHGgZ49v[2WwdILheIlwdi1iYX7kJJRqdWVvZHXw[Y5l\W62IH3hco5meg>?	NXjrNJZVRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkSyNlM5ODFpPkK0NlI{QDBzPD;hQi=>
Huh7	MVPGeY5kfGmxbjDBd5NigQ>?	Mn\BNE4yNzBwNT:xMlAh\|ryP	NWLteZROOjSq		MkT0d5VxeHKnc4Pld{B[XEiGQ{Kg[4Vv\SCneIDy[ZN{cW:w	M4rBcVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2Mk[5OlczLz5{NEK2PVY4OjxxYU6=
hMSCs	M1T4cmZ2dmO2aX;uJGF{e2G7	MWS2MlI2KG6P	Ml7wNlQhcA>?	M1v2[2ROW09?	NV\wOI9Xe3SjYnnsbZpmeyCKaYP0c45mKEGlZYT5cIF1cW:wIHHu[EB1cGViRYjwdoV{e2mxbjDv[kBRdHW{aYDveIVvfCCJZX7ldy=>	MYm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDNzMkO1Okc,OjR\|MUKzOVY9N2F-
HT29	M2S0[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M4XBbVE5OCCwTR?=	NXriSJd7PzJiaB?=		MnfwTWM2OCCxZjCxPFAhdk1?	NXntNXBrRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkSzOlgzPjVpPkK0N\|Y5OjZ3PD;hQi=>
RPE	MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M{HkVlAvOi9yLkSvNE45NzFizszN	NXzpVWZjOjRxNEivO\|IhcA>?	MW\EUXNQ	Ml6wbY5pcWKrdIOgeIhmKHC{b3zp[oVz[XSrb36gZpkh[2WubDDjfYNt\SCjcoLld5Q>	M1vlfVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2NEW2OlAzLz5{NES1OlYxOjxxYU6=
U87 GBM	NHfKXmRHfW6ldHnvckBCe3OjeR?=	MXmxNFAwPTByIF7t	NYXkRWtbPDhiaB?=	MkjBNVAxLSCndHjhco9t	NH;zU2tKdmS3Y3XzJHNmdmW\|Y3XuZ4UuVGmtZTDBcJRmemG2aX;ud{BqdiCQdXPs[YFzKE2xcoDoc4xw\3l?	NYjZRmJqRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS0OlQ5PDFpPkK0OFY1QDRzPD;hQi=>
U87 GBM	MkDtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NXL4eIJ7OTByL{OwNE82ODBibl2=	M1fMSlczKGh?	MoDoNVAxLSCndHjhco9t	M2HPVZJm\HWlZYOgcYVidiClZXzsJI52dWKncjDifUA{OSxiNUSsJIFv\CB3ONMgKS=>	NUj4UIZtRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS0OlQ5PDFpPkK0OFY1QDRzPD;hQi=>
ACP03	Moq3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NF;K[W4zPTBxM{WwM\|UxOG6P	NGjtc\|EzPGh?		MY\k[YNz\WG\|ZYOgZ4VtdCC4aXHibYxqfHlib3[gZZBxem:6aX3heIVtgSB5MNMgKUBifCB{NUFCpI5O	Mm\MQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR4Nki1OFcoRjJ2Nk[4OVQ4RC:jPh?=
ACP02	NYjkXFJ7T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MXqyOVAwOzVyL{WwNI5O	NYO1NGYxOjSq		NH3UV2pl\WO{ZXHz[ZMh[2WubDD2bYFjcWyrdImgc4Yh[XCycn;4bY1ifGWueTC3NOKhLSCjdDCyOVDDqG6P	MX:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDZ4OEW0O{c,OjR4Nki1OFc9N2F-
HeLa	MYrGeY5kfGmxbjDBd5NigQ>?	MUWxcW0>	NF;hUWwxNjWq		MVjhZo9tcXOqZYOgeIhmKHSxdHHsJGhFSUNiYXP0bZZqfHl?	M1PldVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2N{C3OFc1Lz5{NEewO\|Q4PDxxYU6=
HMEC-1	NU\aZ4VCTnWwY4Tpc44hSXO\|YYm=	NYHkdXBuOzBybl2=	MofDNlRp		NIL0b3dqdmO{ZXHz[ZMh\XiycnXzd4lwdiCxZtMgWmVITlJ\|wrDtVm5C	NFn6eJM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEexNFY{OSd-MkS3NVA3OzF:L3G+
HeLa	Mk\YS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NYe1Xm5rOs7:TR?=	NIPoNZk1QGh?		NUXGXVRJ\GWlcnXhd4V{KGOnbHygeoli[mmuaYT5JIFjd3W2IEK1KS=>	M3G0TFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2OES2NVM2Lz5{NEi0OlE{PTxxYU6=
LNCaP	Mn;CS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MYKxNFAuOTByMH7N	NWjEOFQ1OjSq		M4r4VmlEPTBib3[gN\|Axdk1?	Mn\sQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR6NUS2OVgoRjJ2OEW0OlU5RC:jPh?=
PC3	M13wfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MYSxNFAuOTByMH7N	NFHl[FczPGh?		NF3SNHdKSzVyIH;mJFMxOG6P	M4[0clxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2OEW0OlU5Lz5{NEi1OFY2QDxxYU6=
CNE2	NWPLeYFrT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MkCxNVAxNTZyMH7N	M1POZVI1NzR6L{eybC=>		MWjpcohq[mm2czD0bIUheHKxbHnm[ZJifGmxbjDpckBiKHSrbXWtJIFv\CCmb4PlMYRmeGWwZHXueEBu[W6wZYK=	NUDBVIoxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS5Olk6ODFpPkK0PVY6QTBzPD;hQi=>
HeLa	NWP5bYg1TnWwY4Tpc44hSXO\|YYm=	NETKOGozPTCwTR?=	NEPGV\|cyPmh?	NFfUWnNFVVOR	MWnpcoNz\WG\|ZYOgR3lROUFzIH3SUmEh\XiycnXzd4lwdsLi	M1vKUVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3MUG2Olg5Lz5{NUGxOlY5QDxxYU6=
A549	NHrnd4lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MUWwMlAyNTBwOd88US=>	M1K4U\|czcA>?	NX[ycGwyTE2VTx?=	NXnWNotYUUN3MDDv[kAxNjB4zszN	NEm0O5A9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUG2PVQ6OSd-MkWxOlk1QTF:L3G+
SKOV-3	NUW5U25lT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MVmwMlAyNTBwOd88US=>	NGe3VJE4Omh?	MnXESG1UVw>?	MW\JR\|UxKG:oIECuN\|LPxE1?	NILLTYQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUG2PVQ6OSd-MkWxOlk1QTF:L3G+
A549	MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NHzNTnIxNjFvMd88US=>	MkHBOFhp	MYDEUXNQ	NWPTcFFCUUN3MDDv[kAxNjJ6zszN	MXi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTF4OUS5NUc,OjVzNkm0PVE9N2F-
SKOV-3	Mmm3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NF:5bIwxNjFvMd88US=>	MnPsOFhp	NEjZV3dFVVOR	M3jDdGlEPTBib3[gNE44\|ryP	MnX0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjVzNkm0PVEoRjJ3MU[5OFkyRC:jPh?=
A549	M3jSXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NIfFbIIyNTFyzszN	NVTOU5JGOjSq	MVjEUXNQ	NFK4c5FKSzVyIH;mJFMvOs7:TR?=	NFXtVnA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUG2PVQ6OSd-MkWxOlk1QTF:L3G+
SKOV-3	MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M3nJN\|EuOTEQvF2=	M1jZXFI1cA>?	NUDBdW5VTE2VTx?=	MlvCTWM2OCCxZjC1MlbPxE1?	MXi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTF4OUS5NUc,OjVzNkm0PVE9N2F-
MCF7	NUXafotUT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NXvXbYhbOC14MEDuUS=>	MmTtNlRp	MnrNSG1UVw>?	NFTpfJRKSzVyIH;mJFc2dk1?	MVy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTF7MkeyNUc,OjVzOUK3NlE9N2F-
MDA-MB-231	MnrRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M2K3U\|AuPjBybl2=	MXKyOIg>	MmnWSG1UVw>?	NHf1UmJKSzVyIH;mJFExOG6P	Ml76QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjVzOUK3NlEoRjJ3MUmyO\|IyRC:jPh?=
A431	MVXGeY5kfGmxbjDBd5NigQ>?	MonJOVBvVQ>?	Mk\4Nk83NzF{L{K0bC=>	MYjEUXNQ	Mnr2ZYN1cX[jdHXzJJAzOSCjbnSgbY5pcWKrdIOgRXRHOyCneIDy[ZN{cW:w	NHvvbZE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUO3NVA3QSd-MkWzO\|ExPjl:L3G+
A431	Mk\qRZBweHSxc3nzJGF{e2G7	NFjYOGczNzFyL{WwM\|ExOG6P	M2nSS\|Q5cA>?	NFrpdmNFVVOR	MXfpcohq[mm2czD0bIUh[2WubDDndo94fGh?	NEfxZno9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUO3NVA3QSd-MkWzO\|ExPjl:L3G+
PC3	NXXwWmRtTnWwY4Tpc44hSXO\|YYm=	NV7lUo4xOC5zzszN	MXm0PIg>	NYPDXYtZTE2VTx?=	MnPIbY5lfWOnczDpcoNz\WG\|ZTDv[kBJTEGFMTDhcoQhUESDQ{Kgc44hW2y3ZzDn[Y5meyCycn;tc5Rmeg>?	MnHTQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV2M{S5PVcoRjJ3NEO0PVk4RC:jPh?=
SW480	MoO4SpVv[3Srb36gRZN{[Xl?	MmXnNE4y\|ryP	NFX2Ro81QGh?	M1ywT2ROW09?	NYjuOI4zcW6mdXPld{BqdmO{ZXHz[UBw\iCKRFHDNUBidmRiSFTBR\|Ihd25iU3z1[{Bo\W6nczDwdo9ud3Snch?=	NWjtfFM2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW0N\|Q6QTdpPkK1OFM1QTl5PD;hQi=>
PC3	NUP3RYYxTnWwY4Tpc44hSXO\|YYm=	M{\qO\|AvOc7:TR?=	MWe0PIg>	NXrDN2M5TE2VTx?=	MXrheJRmdnWjdHXzJIlvfmG\|aX;uJIFv\CCvaXfyZZRqd25?	NXjsSXRIRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW0N\|Q6QTdpPkK1OFM1QTl5PD;hQi=>
PC3	M4fQTWZ2dmO2aX;uJGF{e2G7	NX\6b3I5OC5zzszN	NIizZXc1QGh?	NVThW49{TE2VTx?=	NUntPZlDemW4ZYLz[ZMhTU2W	MYO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTR\|NEm5O{c,OjV2M{S5PVc9N2F-
SW480	M3rFb2Z2dmO2aX;uJGF{e2G7	NFrrfZUxNjIQvF2=	MmfNOFhp	M1v3WWROW09?	Mkf3ZZR1\W63YYTld{Bqdn[jc3nvckBidmRibXnndoF1cW:w	M4PUeFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3NEO0PVk4Lz5{NUSzOFk6PzxxYU6=
SW480	MWXGeY5kfGmxbjDBd5NigQ>?	Mn;RNE4y\|ryP	MX20PIg>	NYWyTFBiTE2VTx?=	M1HyOpJmfmW{c3XzJGVOXA>?	MlvwQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV2M{S5PVcoRjJ3NEO0PVk4RC:jPh?=
MEFs	NEjYNodHfW6ldHnvckBCe3OjeR?=	M2rtS\|XPxE1?	NEjwV2QyPmh?		NIjVd4VqdmO{ZXHz[ZMhfGinIFXQSWMh[XS2YXPocYVvfCxiVHnyJIRmdGm4ZYL5JIFv\CC2aHWg[YZncWOrZX7jfUBw\iCyZXTld5RidCCob4LtZZRqd25?	NUm2eG5{RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW0PFI3OzRpPkK1OFgzPjN2PD;hQi=>
TE13	M1zlNWFxd3C2b4Ppd{BCe3OjeR?=	NEXnbGkxNjQQvF2=	M4DVSlI1cA>?		M4PYcIlvcGmkaYTzJJRp\SClZXzsJJBzd2yrZnXyZZRqd25?	MUO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTV5OU[2OUc,OjV3N{m2OlU9N2F-
TE13	MUjGeY5kfGmxbjDBd5NigQ>?	NID6N5gxNjQQvF2=	NHTUTWEzPGh?		M1TibpVxNXKnZ4XsZZRmeyCUQWPTSlVCKGyndnXs	MXG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTV5OU[2OUc,OjV3N{m2OlU9N2F-
HEK 293	MY\GeY5kfGmxbjDBd5NigQ>?	MlHtNE44\|ryP	NHu3e2MzPGh?	NULKTmRD\XSqYX7vcC=>	MoTa[Y5p[W6lZYOgSW5iSyCjY3X0fYxifGmxbjDhcoQhcW6lcnXhd4V{KEWQYVOgZYJ2dmSjbnPlJIlvKHSqZTD0c5RidCClZXzsJIx6e2G2ZTDhcoQh[XRidHjlJINmdGxic4Xy[oFk\Q>?	Ml21QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV5OEewO\|koRjJ3N{i3NFc6RC:jPh?=
MDA-MB-231	NETvWFVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NXrNSoh7OjVvNECwJI5O	M2PBZ\|Q5KGh?		MkHXTWM2OCCxZjCyOlMvOm6PwrC=	M3[5dFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ\|MEW1NVk5Lz5{M{C1OVE6QDxxYU6=
MCF-7	MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MX[yOU01ODBibl2=	NYXLeVd1PDhiaB?=		MUXJR\|UxKG:oIEKyNE41dk1?	M4O5WFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ\|MEW1NVk5Lz5{M{C1OVE6QDxxYU6=
ECC-1	NWTJdmU1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MljRNVAxKG6P	MojINlQhcA>?	MX;leIhidm:u	NIDTdHJqdmO{ZXHz[ZMhfGinIIDyc5BwenSrb36gc4Yh[XCxcITveIlkKG63Y3zlbUB1dyB\|NTW=	Mkm2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjNyMki4NFMoRjJ\|MEK4PFA{RC:jPh?=
HEC-1A	NXyxXY1uT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NFPmdmkyODBibl2=	MY[yOEBp	Ml\m[ZRp[W6xbB?=	MUfpcoNz\WG\|ZYOgeIhmKHC{b4DvdpRqd25ib3[gZZBweHSxdHnjJI52[2ynaTD0c{A{QSV?	M1rOV\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ\|MEK4PFA{Lz5{M{CyPFgxOzxxYU6=
NHAC-kn	MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NXjE[VRmOTBxMUCwM\|UxOCCwTR?=	NH\nU4kyOiCq	NV6weopnTE2VTx?=	Ml7LTWM2OCCxZjC1NFBvVQ>?	MV:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzBzN{i3NUc,OjNyMUe4O\|E9N2F-
A549	M1;ROmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NX\RNYNPOjVyIH7N	MVi2MVczKGh?	NFTXeJBFVVOR	MnHsZ4F2e2W\|IHGg[5Jm[XSncjDpcohq[mm2b4L5JIVn\mWldDDjc41jcW6nIIfpeIghXFiWIH;yJIVzdG:2aX7pZi=>	NFrxTVU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{Mkm5OFc5OCd-MkK5PVQ4QDB:L3G+
MG-63	NGq2V\|FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MVSzNFAhdk1?	M3vM[FEzKGh?	M3WxbmROW09?	MYLpcohq[mm2czD0bIUh[2WubDDndo94fGhidH:gPFYm	MVy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjd7OUOzPEc,OjJ5OUmzN\|g9N2F-
MG-63	MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MlGyN\|AxKG6P	MkLMNlQhcA>?	NV\4WYFrTE2VTx?=	NEnEbHlqdmirYnn0d{B1cGViY3XscEBoem:5dHigeI8hPjdn	M4PZR\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{N{m5N\|M5Lz5{Mke5PVM{QDxxYU6=
MG-63	M37GbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M{[3ZVMxOCCwTR?=	M2PiR\|Q5KGh?	MVfEUXNQ	M33kRYlvcGmkaYTzJJRp\SClZXzsJIdzd3e2aDD0c{A2PiV?	NG\PZYQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{Mke5PVM{QCd-MkK3PVk{Ozh:L3G+
HL60	NUHFXIF1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MYGxOVAuOzVyIH7N	MVeyOEBp		NUSzXmlOcW6lcnXhd4V{KGOnbHygZZBweHSxc3nzxsB4cGWwIHPvcoNmdnS{YYTpc45{KGirZ3jldkB1cGGwIEK1NEBvVQ>?	NIHoPJc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{Mke1N\|c{QSd-MkK3OVM4Ozl:L3G+
U937	M4PEW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M3rISlE2OC1\|NUCgcm0>	NXHjU5RVOjRiaB?=		NUSwN5FDcW6lcnXhd4V{KGOnbHygZZBweHSxc3nzxsB4cGWwIHPvcoNmdnS{YYTpc45{KGirZ3jldkB1cGGwIEK1NEBvVQ>?	NG[2cYc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{Mke1N\|c{QSd-MkK3OVM4Ozl:L3G+
SCC-6	MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NYHSWppKOjByLUOyNFAhdk1?	NVGwRm9HOTJxMkSvOFghcA>?	NUfh[3RCTE2VTx?=	NFPNclJqdmirYnn0d{B1cGVicILvcIln\XKjdHnvckBw\iCVQ1OtOkBk\WyuczDpckBiKGSxc3WtJIFv\CC2aX3lMYRmeGWwZHXueEBu[W6wZYK=	MU[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjV3MkOyNUc,OjJ3NUKzNlE9N2F-
U87	M{\abmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M2[wflExOC1\|MECgcoc>	M4D1S\|I1KGh?		MWrpcohq[mm2czD0bIUh[2WubDDndo94fGhidH:gO\|ImKCCjdDCyNFBv\w>?	M2TSSFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{MkewPFQ6Lz5{MkK3NFg1QTxxYU6=
K562	M{iwdmZ2dmO2aX;uJGF{e2G7	MlnjNUDPxE1?	M1f0elEzKGh?	MYPEUXNQ	NVy2fYpv\W6qYX7j[ZMhfGinIHX4dJJme3Orb36gc4YhWlWQWEOgbY5lfWOnZDDifUA2NWG8YT3D[HI>	M1ntc\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{MUe5NVk5Lz5{MkG3PVE6QDxxYU6=
Reh	Ml\JSpVv[3Srb36gRZN{[Xl?	NEfxXYQxNjNxMTFOwG0>	Ml\ENVIhcA>?	MoH5SG1UVw>?	NEjRUHdmdmijbnPld{B1cGViZYjwdoV{e2mxbjDv[kBTXU6[MzDpcoR2[2WmIHL5JFUu[XqjLVPkVi=>	MV28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjF5OUG5PEc,OjJzN{mxPVg9N2F-
Mv1Lu	MnzaSpVv[3Srb36gZZN{[Xl?		MnvDNVghcHK\|		Mlq1TY5lfWO2aX;uJI9nKHerbHSteJlx\SCyMkGgdJJwdW:2ZYKgZYN1cX[jdHnvckBqdiCvaX7rJG13OUy3IHPlcIx{KGGodHXyJFE5KGi{czDifUBtfWOrZnXyZZNmKGG\|c3H5JJJmdGG2aY\lJJRwKGKjc3HsJIxmfmWuLDDFR\|ExODBiPTCwMlE6KM7:TT6=	NEjPdYQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zN{i4NVI{Oid-MUe4PFEzOzJ:L3G+
HeLa	M3HLT2Z2dmO2aX;uJIF{e2G7		NVfDXpd[OjRiaILz		NH;n[2RKdmS3Y4Tpc44hd2ZicEKxJIV5eHKnc4Ppc44hcW5iaIXtZY4hUGWOYTDj[YxteyCjZoTldkAzPCCqcoOsJGVEOTByMDC9JFAvODFzNTFOwG0v	MV[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQDN7N{iyOkc,OTh\|OUe4NlY9N2F-
Mv1Lu	M{\BSGZ2dmO2aX;uJIF{e2G7		MmjNNlQhcHK\|		NYXNPIplUW6lcnXhd4UhcW5iaIXtZY4hf2muZDD0fZBmKHB{MTDwdo91\WmwIHX4dJJme3Orb36gbY4hdWmwazDNelFNfSClZXzsd{Bi\nSncjCyOEBpenNiYomgdFIyKHC{b33veIVzKGG\|c3H5MEBGSzFyMECgQUAxNjB{IN88UU4>	MUK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDl7N{W3PEc,OjR7OUe1O\|g9N2F-
HCT 116	NXT0OWlESW62aYDyc4xq\mW{YYTpeoUh[XO\|YYm=				M{POZmlvKH[rdILvJIFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iY3;sc44h[2GwY3XyJGhEXCBzMU[gZ4VtdHNiZHX0[ZJucW6nZDDifUBOVVRiYYPzZZktKEWFNUCgQUAyKM7:TT6=	M{\XZ\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzFzNUm3OFE{Lz5zMUW5O\|QyOzxxYU6=
T24	Ml;BSpVv[3Srb36gZZN{[Xl?				NIXXTlJEd26lZX70doF1cW:wIH;mJINwdXCxdX7kJJJmeXWrcnXkJIZweiCjY3X0fYxifGmxbjDv[kBpcXO2b37lMVQhcW5iaIXtZY4hXDJ2IHPhcoNmeiClZXzsd{whTUN3MDC9JFEh\|ryPLh?=	NYjNPFRORGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUG1PVc1OTNpPkGxOVk4PDF\|PD;hQi=>
T24	NVHL[3NWTnWwY4Tpc44h[XO\|YYm=				MVvJcohq[mm2aX;uJI9nKGGlZYT5cIF1cW:wIH;mJIhqe3SxbnWtOEBqdiCqdX3hckBVNTJ2IHPhcoNmeiClZXzsd{whTUN3MDC9JFEh\|ryPLh?=	MojFQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTR4MUOzNVIoRjF2NkGzN\|EzRC:jPh?=
T24	M4exd2Z2dmO2aX;uJIF{e2G7				M{jRb2lvcGmkaYTpc44hd2ZiYXPleJlt[XSrb36gc4YhcGm\|dH;u[U01KGmwIHj1cYFvKFRvMkSgZ4Fv[2W{IHPlcIx{NCCHQ{WwJF0hPCEQvF2u	MXy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPDZzM{OxNkc,OTR4MUOzNVI9N2F-
T24	M3\EXmZ2dmO2aX;uJIF{e2G7				M{HWUWlv\HWldHnvckBw\iCjbIDoZUB1fWK3bHnuJIFk\XS7bHH0bY9vKGmwIHj1cYFvKFR{NDDj[YxteyxiRVO1NEA:KDBwMEGg{txONg>?	MoTwQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTlzMUG0OlYoRjF7MUGxOFY3RC:jPh?=
T24	NGr3RWtHfW6ldHnvckBie3OjeR?=				NWW0OYoxUW6mdXP0bY9vKG:oIHjpd5RwdmViSEOgZYNmfHmuYYTpc44hcW5iaIXtZY4hXDJ2IHPlcIx{NCCHQ{WwJF0hOC5yMTFOwG0v	NI\JRpo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOUGxNVQ3Pid-MUmxNVE1PjZ:L3G+
HepG2	MnSxSpVv[3Srb36gZZN{[Xl?				NUXKbnd5XXBvcnXneYxifGmxbjDv[kB1emGwc3PybZB1cW:wYXygZYN1cX[rdImgc4YhcHWvYX6gR2xCNTFicILvcY91\XJicnXnbY9vKC1zMEW1JJRwKC14MnLwJJRz[W6\|ZnXjeIVlKGmwIFjldGczKGOnbHzzJIJ6KGy3Y3nm[ZJie2VicnXwc5J1\XJiZ3Xu[UBie3OjeTygSWM2OCB;IECuN\|gh\|ryPLh?=	MV28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTV3NkGwNkc,OjV3NU[xNFI9N2F-
HeLa	M2PTNGZ2dmO2aX;uJIF{e2G7				MWfJcohq[mm2aX;uJI9nKEiGQVO2JIlvKGi3bXHuJGhmVGFiY3XscJMh[XO\|ZYPz[YQh[XNiaX7obYJqfGmxbjDv[kB1fWK3bHnuJIRm[WOndInsZZRqd25iaX7jeYJifGWmIH\vdkBwfmW{bnnnbJQh[nliY1XMTXNCNCCHQ{WwJF0hOC5yMEWyJO69VS5?	MmHHQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjZ4MUG5NVkoRjJ4NkGxPVE6RC:jPh?=
HL60	M1K0XGFvfGmycn;sbYZmemG2aY\lJIF{e2G7		MnzqNlQhcHK\|		Mke3RY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6\|dDDoeY1idiCKTE[wJINmdGy\|IHHmeIVzKDJ2IHjyd{BjgSCPVGSgZZN{[XluIFfJOVAhRSByLkW5JO69VS5?	MXi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR3NEmxPEc,Ojl2NUS5NVg9N2F-
MDA-MB-435	NXmzb5lDSW62aYDyc4xq\mW{YYTpeoUh[XO\|YYm=		MUGyOEBpenN?		MYnBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKE2GQT3NRk01OzViY3XscJMh[W[2ZYKgNlQhcHK\|IHL5JG1VXCCjc4PhfUwhT0l3MDC9JFEvPzhizszNMi=>	NEnjRmU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUS1OFkyQCd-Mkm0OVQ6OTh:L3G+
K562	NHLZSpJHfW6ldHnvckBie3OjeR?=				M1jYOWlvcGmkaYTvdpkh[WO2aY\peJkh[WejaX7zeEBx[XK2aXHscJkheHW{aX\p[YQhcGm\|dH;u[UBl\WGlZYT5cIF{\SCxZjDoeY1idiCuZYXr[Y1q[SCNNU[yJINmdGy\|LjygTWM2OCB;IECuNFA1PiEQvF2u	NFf4VZg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zMESyOVEyOCd-MUC0NlUyOTB:L3G+
A20	MoX5SpVv[3Srb36gZZN{[Xl?				NG\xeXlKdiC4aYTyc{Bnd3JiYX70bU1JTEGFMTCoTIl{fG:wZTDk[YFk\XS7bHHz[UAyMSCjY4Tpeol1gSCrbjDtc5V{\SCDMkCgZ4VtdHNuIFnDOVAhRSByLkCwNkDPxE1w	NUD6bYd1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUG5OlA1QDlpPkGxPVYxPDh7PD;hQi=>
K 562	MUHGeY5kfGmxbjDhd5NigQ>?				Mon0TY5pcWKrdH;yfUBi[3Srdnn0fUBi\2GrboP0JGhqe3SxbnWg[IVi[2W2eXzhd4UhMEiGQVOpJIlvKEtiNU[yJIVzgXSqcn;s[ZVs\W2rYTDj[YxteyxiSVO1NEA:KDBwMECzOEDPxE1w	NVjYbm5tRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUS1PVI1PzNpPkG0OVkzPDd\|PD;hQi=>
friend cell	MmKzSpVv[3Srb36gZZN{[Xl?				M1r5Z2lvcGmkaYTvdpkh[2:wY3XueJJifGmxbjDh[4FqdnO2IH\ybYVv\CClZXzsd{Bxem:uaX\ldoF1cW:wLDDJR\|UxKD1iMD6wOEDPxE1w	NVLtcphPRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUS2NVM{OTJpPkG0OlE{OzF{PD;hQi=>
SNU-16	M3Toc2Z2dmO2aX;uJIF{e2G7				MVvJcohq[mm2b4L5JIFkfGm4aYT5JIFo[Wmwc4SgTIl{fG:wZTDk[YFk\XS7bHHz[UApUESDQzmg[pJwdSCVTmWtNVYhMGi3bXHuJIdie3S{aXOgZYRmdm:lYYLjbY5wdWFrIHPlcIx{NCCLQ{WwJF0hOC5yNUOyPUDPxE1w	M4fETFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF2Nk[3NlI4Lz5zNE[2O\|IzPzxxYU6=
melanoma B16/BL6	MX7GeY5kfGmxbjDhd5NigQ>?				M{PYNGlvcGmkaYTvdpkh[WO2aY\peJkh[WejaX7zeEBpcXO2b37lJIRm[WOndInsZZNmeyBqSFTBR\|EqKHC{ZYDhdoVlKG[{b32gcY92e2VibXXsZY5wdWFiQkG2M2JNPiClZXzsd{whUUN3MDC9JFAvODF7IN88UU4>	M{PpdVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF3MUC5OlI3Lz5zNUGwPVYzPjxxYU6=
melanoma B16/BL6	MlviSpVv[3Srb36gZZN{[Xl?				NHn1RYhKdmirYnn0c5J6KGGldHn2bZR6KGGpYXnud5QhcGm\|dH;u[UBl\WGlZYT5cIF{\SBqSFTBR\|QqKHC{ZYDhdoVlKG[{b32gcY92e2VibXXsZY5wdWFiQkG2M2JNPiClZXzsd{whUUN3MDC9JFAvODJizszNMi=>	MWO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPTFyOU[yOkc,OTVzMEm2NlY9N2F-
melanoma B16/BL6	MofNSpVv[3Srb36gZZN{[Xl?				NHewTWhKdmirYnn0c5J6KGGldHn2bZR6KGGpYXnud5QhcGm\|dH;u[UBl\WGlZYT5cIF{\SB4IIDy[ZBiemWmIH\yc40hdW:3c3WgcYVt[W6xbXGgRlE3N0KONjDj[YxteyxiSVO1NEA:KDBwMEK4JO69VS5?	NFPVS4E9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zNUGwPVYzPid-MUWxNFk3OjZ:L3G+
melanoma B16/BL6	M3HHTmZ2dmO2aX;uJIF{e2G7				NYW2ToMxUW6qaXLpeI9zgSCjY4Tpeol1gSCjZ3HpcpN1KGirc4TvcoUh\GWjY3X0fYxie2ViODDwdoVx[XKnZDDmdo9uKG2xdYPlJI1mdGGwb33hJGIyPi:ETE[gZ4VtdHNuIFnDOVAhRSByLkC0JO69VS5?	MWW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPTFyOU[yOkc,OTVzMEm2NlY9N2F-
293T	M2q3dWZ2dmO2aX;uJIF{e2G7				M2[4S2lvcGmkaYTpc44hd2ZiaIXtZY4hcGm\|dH;u[UBl\WGlZYT5cIF{\SB2IIDy[ZBiemWmIH\yc40hOjl\|VDDj[YxteyxiSVO1NEA:KDBwMEKg{txONg>?	MWS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPTR3NEKyOEc,OTV2NUSyNlQ9N2F-
293T	MoPrSpVv[3Srb36gZZN{[Xl?				NXPL[\|hsUW6qaXLpeIlwdiCxZjDoeY1idiCqaYP0c45mKGSnYXPleJlt[XOnIEGgdJJmeGG{ZXSg[pJwdSB{OUPUJINmdGy\|LDDJR\|UxKD1iMD6wNkDPxE1w	NHPrXJE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zNUS1OFIzPCd-MUW0OVQzOjR:L3G+
293T	NIHYUmpHfW6ldHnvckBie3OjeR?=				MonFTY5pcWKrdHnvckBw\iCqdX3hckBpcXO2b37lJIRm[WOndInsZZNmKDZicILldIFz\WRiZoLvcUAzQTOWIHPlcIx{NCCLQ{WwJF0hOC5yMjFOwG0v	NV7zXVU2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUW0OVQzOjRpPkG1OFU1OjJ2PD;hQi=>
293T	NUDnd5dWTnWwY4Tpc44h[XO\|YYm=				NEO0PHlKdmirYnn0bY9vKG:oIHj1cYFvKGirc4TvcoUh\GWjY3X0fYxie2ViODDwdoVx[XKnZDDmdo9uKDJ7M2SgZ4VtdHNuIFnDOVAhRSByLkC0JO69VS5?	MV68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPTR3NEKyOEc,OTV2NUSyNlQ9N2F-
HeLa	MmfOSpVv[3Srb36gZZN{[Xl?				NIG5VYpKdmirYnn0c5J6KGOxbnPlcpRz[XSrb36gZYdicW6\|dDDoeY1idiCqaYP0c45mKGSnYXPleJlt[XOnIDjISGFEMSCocn;tJGhmVGFiY3XscJMhf2m2aDDzeYJ{fHKjdHWgOYEtKEmFNUCgQUAxNjB3NEWg{txONg>?	MnHrQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTV2NU[yOlcoRjF3NEW2NlY4RC:jPh?=
HCT116	M{PaWWFvfGmycn;sbYZmemG2aY\lJIF{e2G7				NUH5SnU{SW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBJS1RzMU[gZ4VtdHNuIFnDOVAhRSByLkCwNVMh\|ryPLh?=	MlnBQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTZ7MES4PVAoRjF4OUC0PFkxRC:jPh?=
H1299	Mn3FRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl?				NFrDfXpCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JGgyOjl7IHPlcIx{NCCLQ{WwJF0hOC5zIN88UU4>	M3z1OlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF4OUC0PFkxLz5zNkmwOFg6ODxxYU6=
H661	NXz3dZNmSW62aYDyc4xq\mW{YYTpeoUh[XO\|YYm=				NGr2e\|hCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JGg3PjFiY3XscJMtKEmFNUCgQUAxNjNizszNMi=>	NWLpXpcyRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMU[5NFQ5QTBpPkG2PVA1QDlyPD;hQi=>
H661	MmXpRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl?		MoTXOFghcHK\|		MlvQRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6\|dDDIOlYyKGOnbHzzJIFnfGW{IES4JIhzeyCkeTDYWHQh[XO\|YYmsJGlEPTBiPTCwMlA5PSEQvF2u	MoDxQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTd4MkS3O\|MoRjF5NkK0O\|c{RC:jPh?=
WiDr	NUPFVm5IT3Kxd4ToJIlvcGmkaYTpc44h[XO\|YYm=				NX;kOnF5UW6qaXLpeIlwdiCxZjDTRXAyOzBibXXkbYF1\WRiY3XscEBoem:5dHigbY4hcHWvYX6gW4lFeiClZXzsd{whUUN3MDC9JFAvPTd5NjFOwG0v	MVm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPzZ2M{GxNkc,OTd4NEOxNVI9N2F-
U251	Mn74SpVv[3Srb36gZZN{[Xl?				NHzMSWdKdmirYnn0bY9vKG:oIGPBVFE{OCCrbjDWSWdHNXO2aX31cIF1\WRiaIXtZY4hXTJ3MTDj[YxteyCkeTDQUGFRKHKncH;yeIVzKGenbnWgZZN{[XluIFnDOVAhRSByLk[xNVIh\|ryPLh?=	NXf6OmFWRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUe2OFMyOTJpPkG3OlQ{OTF{PD;hQi=>
293T	NULETFl4TnWwY4Tpc44h[XO\|YYm=				M2HVUGlvcGmkaYTpc44hd2ZiaIXtZY4hUESDQ{Gg[ZhxemW\|c3XkJIlvKDJ7M2SgZ4VtdHNuIFnDOVAhRSByLkCwNVkh\|ryPLh?=	NV3nbZpkRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUe4PFEzOzJpPkG3PFgyOjN{PD;hQi=>
293T	M1rSfGZ2dmO2aX;uJIF{e2G7				MVfJcohq[mm2aX;uJI9nKGi3bXHuJGhFSUN2IHX4dJJme3OnZDDpckAzQTOWIHPlcIx{NCCLQ{WwJF0hOC5yMEKg{txONg>?	NX7SdGxxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUe4PFEzOzJpPkG3PFgyOjN{PD;hQi=>
293T	MXXGeY5kfGmxbjDhd5NigQ>?				MonaTY5pcWKrdHnvckBw\iCvb4Xz[UBJTEGFNjDlfJBz\XO\|ZXSgbY4hOjl\|VDDj[YxteyxiSVO1NEA:KDBwMECyPEDPxE1w	M4Dxe\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF5OEixNlMzLz5zN{i4NVI{OjxxYU6=
H661	MXLBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>?		NX;RdYI3PDhiaILz		NUPBXHJmSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBJPjZzIHPlcIx{KGGodHXyJFQ5KGi{czygTWM2OCB;IECuNFg2KM7:TT6=	MnLjQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTd6OUe4NlQoRjF5OEm3PFI1RC:jPh?=
293T	MYXGeY5kfGmxbjDhd5NigQ>?				NETVeWpKdmirYnn0bY9vKG:oIFjERWMyKGW6cILld5Nm\CCrbjCyPVNVKGOnbHzzMEBKSzVyIE2gNE4yQSEQvF2u	NV;Ie2JrRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUe5NFA6OTFpPkG3PVAxQTFzPD;hQi=>
293T	MVfGeY5kfGmxbjDhd5NigQ>?				M3vGcWlvcGmkaYTpc44hd2ZiSFTBR\|Qh\XiycnXzd4VlKGmwIEK5N3Qh[2WubIOsJGlEPTBiPTCwMlIh\|ryPLh?=	NVy5NJVXRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUe5NFA6OTFpPkG3PVAxQTFzPD;hQi=>
293T	NXHWfFJZTnWwY4Tpc44h[XO\|YYm=				NITSRmRKdmirYnn0bY9vKG:oIFjERWM3KGW6cILld5Nm\CCrbjCyPVNVKGOnbHzzMEBKSzVyIE2gNE4zQCEQvF2u	Ml\4QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTd7MEC5NVEoRjF5OUCwPVEyRC:jPh?=
NIH3T3	Mn\XSpVv[3Srb36gZZN{[Xl?				MmXuTY5pcWKrdHnvckBw\iCqdX3hckBz\WOxbXLpcoFvfCCKRFHDNUBmgHC{ZYPz[YQhcW5iTlnIN3Q{KGOnbHzzMEBKSzVyIE2gNE4xOjFizszNMi=>	NXjIR5J{RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUe5Nlk4QThpPkG3PVI6Pzl6PD;hQi=>
human 293	NH3ZXnNHfW6ldHnvckBie3OjeR?=				MnzjTY5pcWKrdHnvckBw\iCqdX3hckBz\WOxbXLpcoFvfCCKRFHDOEBmgHC{ZYPz[YQhcW5iMkmzJINmdGy\|LDDJR\|UxKD1iMD6wN\|Qh\|ryPLh?=	NW\PcWVsRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUe5Nlk4QThpPkG3PVI6Pzl6PD;hQi=>
mouse 293	MU\GeY5kfGmxbjDhd5NigQ>?				MmrsTY5pcWKrdHnvckBw\iCvb4Xz[UBz\WOxbXLpcoFvfCCKRFHDOkBmgHC{ZYPz[YQhcW5iMkmzJINmdGy\|LDDJR\|UxKD1iMD6wPFEh\|ryPLh?=	NULhWYF4RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUe5Nlk4QThpPkG3PVI6Pzl6PD;hQi=>
SKBR3	NHTPTFVCdnSrcILvcIln\XKjdHn2[UBie3OjeR?=				NU\yb5JESW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDTT2JTOyClZXzsd{whUUN3MDC9JFAvODJizszNMi=>	NFvVXII9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOEK0O\|U2PCd-MUiyOFc2PTR:L3G+
MM96L	MWXGeY5kfGmxbjDhd5NigQ>?				MmXjTY5pcWKrdHnvckBw\iCqdX3hckBOVTl4TDDj[YxteyxiSVO1NEA:KDBwMEOg{txONg>?	MnXJQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTh{NEe1OVQoRjF6MkS3OVU1RC:jPh?=
SNU16	MnjsSpVv[3Srb36gZZN{[Xl?				MW\Jcohq[mm2aX;uJI9nKEiGQVOg[pJwdSCqdX3hckBUVlVzNjDj[YxteyxiSVO1NEA:KDBwMEWzJO69VS5?	NX7T[FZtRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUiyOFc2PTRpPkG4NlQ4PTV2PD;hQi=>
A549	NH3uSVJCdnSrcILvcIln\XKjdHn2[UBie3OjeR?=				NEH0Uo1CdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFG1OFkh[2WubIOsJGlEPTBiPTCwMlA5KM7:TT6=	M1jnSFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF6MkS3OVU1Lz5zOEK0O\|U2PDxxYU6=
MKN45	NULi[4k3SW62aYDyc4xq\mW{YYTpeoUh[XO\|YYm=				Ml3YRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6\|dDDoeY1idiCPS160OUBk\WyuczygTWM2OCB;IECuNUDPxE1w	M2\u[\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF6MkS3OVU1Lz5zOEK0O\|U2PDxxYU6=
SQ20B	MnexSpVv[3Srb36gZZN{[Xl?				MlLkTY5pcWKrdHnvckBw\iCqdX3hckBUWTJyQjDj[YxteyxiSVO1NEA:KDBwMjFOwG0v	MWW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQDJ2N{W1OEc,OTh{NEe1OVQ9N2F-
neonatal foreskin fibroblasts	NIC4RVJIem:5dHigbY5pcWKrdHnvckBie3OjeR?=				NWDK[lQ5T3Kxd4ToJIlvcGmkaYTpc44hd2ZiaIXtZY4hdmWxbnH0ZYwh\m:{ZYPrbY4h\mmkcn;icIF{fHNiY3XscJMtKEmFNUCgQUAxNjJizszNMi=>	NFjafm89[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOEK0O\|U2PCd-MUiyOFc2PTR:L3G+
HeLa	MYfGeY5kfGmxbjDhd5NigQ>?				NHvuPYNKdmirYnn0bY9vKG:oIFjERWMh\nKxbTDoeY1idiCKZVzhJINmdGy\|LDDJR\|UxKD1iMD6zJO69VS5?	MUW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQDJ2N{W1OEc,OTh{NEe1OVQ9N2F-
MM96L/NFF	M3ywR2Z2dmO2aX;uJIF{e2G7				NY\2b5pxW2WuZXP0bZZqfHliaX7k[ZgtKHKjdHnvJI9nKEmFNUCg[o9zKGi3bXHuJG1OQT[OIHPlcIx{KHSxIFnDOVAh\m:{IHj1cYFvKE6IRjDj[YxteyxiSVO1NEA:KDZwNzFOwG0v	NFrvO\|M9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOEK0O\|U2PCd-MUiyOFc2PTR:L3G+
293T	MW\GeY5kfGmxbjDhd5NigQ>?				M4P5[mlvcGmkaYTpc44hd2ZiaIXtZY4hUESDQ{Gg[ZhxemW\|c3XkJIlvKDJ7M2SgZ4VtdHNuIFnDOVAhRSByLkCzOlYh\|ryPLh?=	NXS1WJh5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUizPVc5OjZpPkG4N\|k4QDJ4PD;hQi=>
293T	M3Sxd2Z2dmO2aX;uJIF{e2G7				NXm0SW1yUW6qaXLpeIlwdiCxZjDoeY1idiCKRFHDOEBmgHC{ZYPz[YQhcW5iMkmzWEBk\WyuczygTWM2OCB;IECuNFYzQSEQvF2u	M4Xl[\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF6M{m3PFI3Lz5zOEO5O\|gzPjxxYU6=
293T	MXrGeY5kfGmxbjDhd5NigQ>?				NHnBXZlKdmirYnn0bY9vKG:oIHj1cYFvKEiGQVO2JIV5eHKnc4Pl[EBqdiB{OUPUJINmdGy\|LDDJR\|UxKD1iMD6wPFM{KM7:TT6=	M3LoWVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF6M{m3PFI3Lz5zOEO5O\|gzPjxxYU6=
HeLa	M4\3O2Z2dmO2aX;uJIF{e2G7				M4roc2lvcGmkaYTpc44hd2ZiaIXtZY4hUESDQzDpckBJ\UyjIHPlcIx{KGK7IH\sc5VzKGSnIHz5d{Bie3OjeTygTWM2OCB;IECuNFA2KM7:TT6=	MXu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQDN7N{iyO{c,OTh\|OUe4Nlc9N2F-
S2	NGqweYpHfW6ldHnvckBie3OjeR?=				M{jvOGlvcGmkaYTpc44hd2ZiUHzhd41w\Gm3bTDmZYxkcXCjcoXtJGhFSUNzIHX4dJJme3OnZDDpckBFem:\|b4DobYxiKG2nbHHuc4die3SncjDTNkBk\WyuczygTWM2OCB;IECuNFAxPiEQvF2u	MmjVQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTl\|MUe0OVAoRjF7M{G3OFUxRC:jPh?=
NCI-H661	NGf0dWFCdnSrcILvcIln\XKjdHn2[UBie3OjeR?=		NIrMXJo1QCCqcoO=		MYTBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKE6FST3IOlYyKGOnbHzzJIFnfGW{IES4JIhzeyCkeTDYWHQh[XO\|YYmsJGlEPTBiPTCwMlEh\|ryPLh?=	NVrXZXVCRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUmzPFU3ODBpPkG5N\|g2PjByPD;hQi=>
NIH3T3	MXvGeY5kfGmxbjDhd5NigQ>?				NFLweoRKdmirYnn0bY9vKG:oIFjERWMyKGmwIHj1cYFvKE6LSEPUN{Bk\WyuczDifUBz[WSrb33leJJq[yCqaYP0c45mKGSnYXPleJlt[XSrb36gZZN{[XluIFnDOVAhRSByLkCwOkDPxE1w	NFvFfVU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOUS1O\|Y2QSd-MUm0OVc3PTl:L3G+
HeLa	NIrZdmxHfW6ldHnvckBie3OjeR?=				NHL1N\|FKdmirYnn0bY9vKG:oIFjERWMh\nKxbTDoeY1idiCKZVzhJINmdGy\|IHL5JIZtfW:{b3flcolkKGWweont[UBie3OjeTygTWM2OCB;IECuN{DPxE1w	NYS1cYx3RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUm0OVc3PTlpPkG5OFU4PjV7PD;hQi=>
ML1	NGrhUGRCdnSrdIXtc5Ih[XO\|YYm=				NYW0Vnh2SW62aYT1cY9zKGGldHn2bZR6KGGpYXnud5QhdW:3c3WgUWwyKGOnbHzzMEBKSzVyIE2gNE4zPSEQvF2u	NHL4OFg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOUWzOFU{PCd-MUm1N\|Q2OzR:L3G+
HCT116	MU\DfZRwfG:6aXPpeJkh[XO\|YYm=		NHG0d48{KGSjeYO=		NYO4b4kyS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hUEOWMUG2JINmdGy\|IHHmeIVzKDNiZHH5d{BjgSCZU2StNUBie3OjeTygTWM2OCB;IECuPEDPxE1w	M4fORVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJyNEWyNlI3Lz5{MES1NlIzPjxxYU6=
HCT116	NFexbZpIem:5dHigbY5pcWKrdHnvckBie3OjeR?=		M4\FSFQ5KGi{cx?=		M1XYemdzd3e2aDDpcohq[mm2aX;uJI9nKGi3bXHuJGhEXDFzNjDj[YxteyCjZoTldkA1QCCqcoOgZpkhW1KEIHHzd4F6NCCLQ{WwJF0hOC5yNEOg{txONg>?	MoXvQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjFyN{OxOlAoRjJzMEezNVYxRC:jPh?=
H460	NGr4dpVIem:5dHigbY5pcWKrdHnvckBie3OjeR?=		M17LblQ5KGi{cx?=		MUnHdo94fGhiaX7obYJqfGmxbjDv[kBpfW2jbjDIOFYxKGOnbHzzJIFnfGW{IES4JIhzeyCkeTDTVmIh[XO\|YYmsJGlEPTBiPTCwMlEh\|ryPLh?=	M1rx[\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzMEezNVYxLz5{MUC3N\|E3ODxxYU6=
DMS53	Mo[4R5l1d3SxeHnjbZR6KGG\|c3H5		MofhNkBl[Xm\|		NGD5d3ZEgXSxc4TheIlkKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gSG1UPTNiY3XscJMh[XO\|ZYPz[YQh[XNiaX7obYJqfGmxbjDv[kBk\WyuIIDyc4xq\mW{YYTpc44h[W[2ZYKgNkBl[Xm\|IHL5JG1VXCCjc4PhfUwhUUN3MDC9JFAvODJ3IN88UU4>	NX;oRYo2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG1NFQzOTRpPkKxOVA1OjF2PD;hQi=>
HeLa	NHvSZldHfW6ldHnvckBie3OjeR?=		M3fiZVIxKG2rboO=		MXPJcohq[mm2aX;uJI9nKEiGQVOgbY4hcHWvYX6gTIVN[SClZXzsd{B2e2mwZzDBZ{1CemdvR3z5MWx6eyiDYzmtRW1EKGG\|IH\seY9z\XOlZX70JJN2[nO2cnH0[UBi\nSncjCyNEBucW6\|IHL5JIZtfW:{ZYPj[Y5k\SCjc4PhfUwhUUN3MDC9JFAvODB\|IN88UU4>	MkPxQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjF4MkG4PFMoRjJzNkKxPFg{RC:jPh?=
Sf9	M{TQSGZ2dmO2aX;uJIF{e2G7		MnHiNUBpeg>?		M3nBXmlvcGmkaYTpc44hd2ZiTjD0[ZJucW6jbDDo[ZhicGm\|dHnkbY5mNXSjZ3fl[EBpfW2jbjDISGFEQCCneIDy[ZN{\WRiaX6gV4Y6KGOnbHzzJIFnfGW{IEGgbJIh[nliZnz1c5Jme2OnbnPlJIF{e2G7LDDJR\|UxKD1iMD65OkDPxE1w	M2GxeVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzN{KzO\|M{Lz5{MUeyN\|c{OzxxYU6=
MCF7	M37HNmFvfGmycn;sbYZmemG2aY\lJIF{e2G7		Ml;0OFghcHK\|		Mor0RY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6\|dDDoeY1idiCPQ1[3JINmdGy\|IHHmeIVzKDR6IHjyd{BjgSCPVGSgZZN{[XluIFnDOVAhRSBzLkeg{txONg>?	NXTTdHJ[RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkK0OlUxQTFpPkKyOFY2ODlzPD;hQi=>
BE(2)-C	MULBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>?		MlzLO\|IhcHK\|		Mln6RY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6\|dDDoeY1idiCERTiyLU1EKGOnbHzzJIFnfGW{IEeyJIhzeyCkeTDBcIFu[XJiYnz1[UBie3OjeTygTWM2OCB;IECuNFUh\|ryPLh?=	M2K3Z\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{OUOyN\|E3Lz5{MkmzNlMyPjxxYU6=
Sf9	M3fhOWZ2dmO2aX;uJIF{e2G7		MWSyJIhzew>?		MmPmTY5pcWKrdHnvckBw\iCqdX3hckBz\WOxbXLpcoFvfCCKRFHDOkBmgHC{ZYPz[YQhcW5iU3[5JINmdGy\|IHnuZ5Vj[XSnZDDmc5IhOiCqcoOgeZNqdmdiUljLT{1C[yCobIXvdo9o\W6rYzDzeYJ{fHKjdHWsJGlEPTBiPTCwMlAxOTJizszNMi=>	MlX3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjNyMEmyNFMoRjJ\|MEC5NlA{RC:jPh?=
Sf9	M{X0eWZ2dmO2aX;uJIF{e2G7		M4LhflIhcHK\|		MVzJcohq[mm2aX;uJI9nKGi3bXHuJJJm[2:vYnnuZY51KEiGQVOxJIV5eHKnc4Pl[EBqdiCVZkmgZ4VtdHNiaX7jeYJifGWmIH\vdkAzKGi{czD1d4lv\yCUSFvLMWFkKG[udX;yc4dmdmmlIIP1ZpN1emG2ZTygTWM2OCB;IECuNFA2KM7:TT6=	MmDnQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjNyMEmyNFMoRjJ\|MEC5NlA{RC:jPh?=
A2780	NXq2TXNKS3m2b4TvfIlkcXS7IHHzd4F6		M4jYfVczKGi{cx?=		NHy1NIhEgXSxdH;4bYNqfHliYXfhbY5{fCClaYPwcIF1cW5icnXzbZN1[W62IHj1cYFvKEF{N{iwJINmdGy\|IHHmeIVzKDd{IHjyd{BjgSCPVGSgZZN{[XluIFnDOVAhRSByLkKyJO69VS5?	M4fLOVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ\|MkWyOlA{Lz5{M{K1NlYxOzxxYU6=
A2780	NHTudGNHfW6ldHnvckBie3OjeR?=		MVexPEBpenN?		NW\Tb2F{UW6qaXLpeIlwdiCxZjDISGFEKGmwIHPpd5Bt[XSrbjDy[ZNqe3SjboSgbJVu[W5iQUK3PFAh[2WubIOgZYZ1\XJiMUigbJJ{KGK7IH\seY9z\XOlZX7j[UBie3OjeTygTWM2OCB;IECuNlUh\|ryPLh?=	MYO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzJ3Mk[wN{c,OjN{NUK2NFM9N2F-
A2780	NIDBVGhEgXSxdH;4bYNqfHliYYPzZZk>		NYnpZWEyPzJiaILz		NYDES2tES3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hSTJ5OECgZ4VtdHNiYX\0[ZIhPzJiaILzJIJ6KE2WVDDhd5NigSxiSVO1NEA:KDBwMkmg{txONg>?	NVjoeZBORGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkOyOVI3ODNpPkKzNlUzPjB\|PD;hQi=>
A2780	MX;GeY5kfGmxbjDhd5NigQ>?		NXHueXJvOThiaILz		NGW0[JhKdmirYnn0bY9vKG:oIFjERWMhcW5iaIXtZY4hSTJ5OECgZ4VtdHNiYX\0[ZIhOThiaILzJIJ6KG[udX;y[ZNk\W6lZTDhd5NigSxiSVO1NEA:KDBwNEOg{txONg>?	MmDhQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN{NUK2NFMoRjJ\|MkWyOlA{RC:jPh?=
Sf9	NVTUNo5LTnWwY4Tpc44h[XO\|YYm=				MXzJcohq[mm2aX;uJI9nKGi3bXHuJJJm[2:vYnnuZY51KEiGQVO2JIV5eHKnc4Pl[EBqdiCkYXP1cI93cXK3cz;z[lkh[2WubIOgeZNqdmdiUljLT2FkKGG\|IIP1ZpN1emG2ZTygTWM2OCB;IECuNFAxQSEQvF2u	NIPESlk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{mwOVY5OCd-MkO5NFU3QDB:L3G+
Sf9	NHjCPFlHfW6ldHnvckBie3OjeR?=				NFLJXlNKdmirYnn0bY9vKG:oIHj1cYFvKHKnY3;tZolv[W62IFjERWMyKGW6cILld5Nm\CCrbjDiZYN2dG:4aYL1d{9{\jliY3XscJMhfXOrbnegVmhMU0GlIHHzJJN2[nO2cnH0[UwhUUN3MDC9JFAvODB3IN88UU4>	NInPNZU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{mwOVY5OCd-MkO5NFU3QDB:L3G+
Sf9	NXHHb5B{TnWwY4Tpc44h[XO\|YYm=				M4LzdWlvcGmkaYTpc44hd2ZiaIXtZY4hemWlb33ibY5idnRiSFTBR\|Ih\XiycnXzd4VlKGmwIHLhZ5Vtd3[rcoXzM5NnQSClZXzsd{B2e2mwZzDSTGtMSWNiYYOgd5Vje3S{YYTlMEBKSzVyIE2gNE4xODVizszNMi=>	NVzad3h3RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO5NFU3QDBpPkKzPVA2PjhyPD;hQi=>
Sf9	NEG5SYNHfW6ldHnvckBie3OjeR?=				NGTsVmZKdmirYnn0bY9vKG:oIHj1cYFvKHKnY3;tZolv[W62IFjERWMyOCCneIDy[ZN{\WRiaX6gZoFkfWyxdnnyeZMwe2Z7IHPlcIx{KHW\|aX7nJHJJU0uDYzDhd{B{fWK\|dILheIUtKEmFNUCgQUAxNjByOTFOwG0v	MoK4QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN7MEW2PFAoRjJ\|OUC1OlgxRC:jPh?=
Sf9	NFPX[2lHfW6ldHnvckBie3OjeR?=				MVTJcohq[mm2aX;uJI9nKGi3bXHuJJJm[2:vYnnuZY51KEiGQVOxNUBmgHC{ZYPz[YQhcW5iYnHjeYxwfmm{dYOvd4Y6KGOnbHzzJJV{cW6pIGLIT2tC[yCjczDzeYJ{fHKjdHWsJGlEPTBiPTCwMlAyPzNizszNMi=>	MWe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzlyNU[4NEc,OjN7MEW2PFA9N2F-
Sf9	NXrnVmRqTnWwY4Tpc44h[XO\|YYm=				MWHJcohq[mm2aX;uJI9nKGi3bXHuJJJm[2:vYnnuZY51KEiGQVO4JIV5eHKnc4Pl[EBqdiCkYXP1cI93cXK3cz;z[lkh[2WubIOgeZNqdmdiUljLRYNMSWNiYYOgd5Vje3S{YYTlMEBKSzVyIE2gNE4yOjlizszNMi=>	NXTrVoU6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO5NFU3QDBpPkKzPVA2PjhyPD;hQi=>
MOLT4	M{LHOWN6fG:2b4jpZ4l1gSCjc4PhfS=>		MoXlO\|IhcHK\|		M4HwOmN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJG1QVFR2IHPlcIx{KGG\|c3Xzd4VlKGG\|IILl[JVkfGmxbjDpckBk\WyuII\pZYJqdGm2eTDh[pRmeiB5MjDodpMh[nliQ1PLPEBie3OjeTygTWM2OCB;IECuNFMh\|ryPLh?=	NEm3cIU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEm2NFYzPyd-MkS5OlA3Ojd:L3G+
A549	MlvJR5l1d3SxeHnjbZR6KGG\|c3H5		MkW2O\|IhcHK\|		M{HURWN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGE2PDliY3XscJMh[XO\|ZYPz[YQh[XNicnXkeYN1cW:wIHnuJINmdGxidnnhZoltcXS7IHHmeIVzKDd{IHjyd{BjgSCFQ1u4JIF{e2G7LDDJR\|UxKD1iMD6wOUDPxE1w	NILMbnU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEm2NFYzPyd-MkS5OlA3Ojd:L3G+
MCF7	NHvoe4pEgXSxdH;4bYNqfHliYYPzZZk>		MWS3NkBpenN?		NGjxNXdEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBOS0Z5IHPlcIx{KGG\|c3Xzd4VlKGG\|IILl[JVkfGmxbjDpckBk\WyuII\pZYJqdGm2eTDh[pRmeiB5MjDodpMh[nliQ1PLPEBie3OjeTygTWM2OCB;IECuNFYh\|ryPLh?=	NVPwR4RTRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS5OlA3OjdpPkK0PVYxPjJ5PD;hQi=>
HL60	Ml64R5l1d3SxeHnjbZR6KGG\|c3H5		MnrMO\|IhcHK\|		M4i5[GN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGhNPjBiY3XscJMh[XO\|ZYPz[YQh[XNicnXkeYN1cW:wIHnuJINmdGxidnnhZoltcXS7IHHmeIVzKDd{IHjyd{BjgSCFQ1u4JIF{e2G7LDDJR\|UxKD1iMD6wPEDPxE1w	MlH0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR7NkC2NlcoRjJ2OU[wOlI4RC:jPh?=
BGC823	M4PHN2N6fG:2b4jpZ4l1gSCjc4PhfS=>		NWHQ[G86PzJiaILz		M{G5OmN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGJISzh{MzDj[YxteyCjc4Pld5Nm\CCjczDy[YR2[3Srb36gbY4h[2WubDD2bYFjcWyrdImgZYZ1\XJiN{KgbJJ{KGK7IFPDT\|gh[XO\|YYmsJGlEPTBiPTCwMlA5KM7:TT6=	M4e3R\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2OU[wOlI4Lz5{NEm2NFYzPzxxYU6=
HuH7	MYnDfZRwfG:6aXPpeJkh[XO\|YYm=		Mom3O\|IhcHK\|		MnrZR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gTJVJPyClZXzsd{Bie3Onc4Pl[EBieyC{ZXT1Z5Rqd25iaX6gZ4VtdCC4aXHibYxqfHliYX\0[ZIhPzJiaILzJIJ6KEOFS{igZZN{[XluIFnDOVAhRSByLkGg{txONg>?	Mnm0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR7NkC2NlcoRjJ2OU[wOlI4RC:jPh?=
U937	M1\rUWN6fG:2b4jpZ4l1gSCjc4PhfS=>		M{PpcVczKGi{cx?=		NYDRT4NWS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hXTl\|NzDj[YxteyCjc4Pld5Nm\CCjczDy[YR2[3Srb36gbY4h[2WubDD2bYFjcWyrdImgZYZ1\XJiN{KgbJJ{KGK7IFPDT\|gh[XO\|YYmsJGlEPTBiPTCwMlEh\|ryPLh?=	MmPjQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR7NkC2NlcoRjJ2OU[wOlI4RC:jPh?=
HeLa	MoTsR5l1d3SxeHnjbZR6KGG\|c3H5		NVLQW4VLPzJiaILz		MWPDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDI[WxiKGOnbHzzJIF{e2W\|c3XkJIF{KHKnZIXjeIlwdiCrbjDj[YxtKH[rYXLpcIl1gSCjZoTldkA4OiCqcoOgZpkhS0ONODDhd5NigSxiSVO1NEA:KDBwMUGg{txONg>?	M4OzclxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2OU[wOlI4Lz5{NEm2NFYzPzxxYU6=
NCI-H1975	NFXafJREgXSxdH;4bYNqfHliYYPzZZk>		NFnWW2U4OiCqcoO=		NELzSoJEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBPS0lvSEG5O\|Uh[2WubIOgZZN{\XO\|ZXSgZZMhemWmdXP0bY9vKGmwIHPlcIwhfmmjYnnsbZR6KGGodHXyJFczKGi{czDifUBES0t6IHHzd4F6NCCLQ{WwJF0hOC5{MTFOwG0v	NFL6TWw9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEm2NFYzPyd-MkS5OlA3Ojd:L3G+
K562	M1zUdmN6fG:2b4jpZ4l1gSCjc4PhfS=>		MoXlO\|IhcHK\|		MmjTR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gT\|U3OiClZXzsd{Bie3Onc4Pl[EBieyC{ZXT1Z5Rqd25iaX6gZ4VtdCC4aXHibYxqfHliYX\0[ZIhPzJiaILzJIJ6KEOFS{igZZN{[XluIFnDOVAhRSByLkSxJO69VS5?	NVHiPHZERGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS5OlA3OjdpPkK0PVYxPjJ5PD;hQi=>
HEK293	MkjWR5l1d3SxeHnjbZR6KGG\|c3H5		NIS1XJc6PiCqcoO=		NV7JcmNsS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hUEWNMkmzJINmdGy\|IHHmeIVzKDl4IHjyd{BjgSCPVGSgZZN{[XluIFnDOVAhRSByLkG2JO69VS5?	NYTwVVUxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW1OVYyODJpPkK1OVU3OTB{PD;hQi=>
LO2	MoPZR5l1d3SxeHnjbZR6KGG\|c3H5		NEWxSGw6PiCqcoO=		MWfDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDMU\|Ih[2WubIOgZYZ1\XJiOU[gbJJ{KGK7IF3UWEBie3OjeTygTWM2OCB;IECuNlEh\|ryPLh?=	M33xNVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3NUW2NVAzLz5{NUW1OlExOjxxYU6=
HeLa	NWP4cGg{S3m2b4TvfIlkcXS7IHHzd4F6		M2T0WVk3KGi{cx?=		NUXlUZF4S3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hUGWOYTDj[YxteyCjZoTldkA6PiCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwJF0hOC56NTFOwG0v	M4\yRVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3NUW2NVAzLz5{NUW1OlExOjxxYU6=
HepG2	NXfzU5pSS3m2b4TvfIlkcXS7IHHzd4F6		NFzLfJc6PiCqcoO=		M3vYO2N6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGhmeEd{IHPlcIx{KGGodHXyJFk3KGi{czDifUBOXFRiYYPzZZktKEmFNUCgQUAxNjl4IN88UU4>	NYj0O\|ZQRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW1OVYyODJpPkK1OVU3OTB{PD;hQi=>
U2OS	MkjXR5l1d3SxeHnjbZR6KGG\|c3H5		MorZPVYhcHK\|		MX3DfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDVNm9UKGOnbHzzJIFnfGW{IEm2JIhzeyCkeTDNWHQh[XO\|YYmsJGlEPTBiPTCxOE46OyEQvF2u	NH\R[oE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUW1OlExOid-MkW1OVYyODJ:L3G+
Sf9	NETSPVBHfW6ldHnvckBie3OjeR?=		NI\hV2U6OCCvaX7z		MojyTY5pcWKrdHnvckBw\iCodXzsJIxmdme2aDDoeY1idiC{ZXPvcYJqdmGwdDDOMZRmem2rbnHsJGdUXC22YXfn[YQhUESDQ{[gLFEhfG9iMUKxOUBz\XOrZIXld{kh\XiycnXzd4VlKGmwIIPmPUBk\WyuczD1d4lv\yCUSFutT{hC[ylvQV3DJIF{KHO3YoP0doF1\SCrbnP1ZoF1\WRiZn;yJFkxKG2rboOgZpkh\my3b4Lld4NmdmOnIHHzd4F6NCCLQ{WwJF0hOC5yMEG3NVYh\|ryPLh?=	MkXSQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjdyNkC3OlQoRjJ5ME[wO\|Y1RC:jPh?=
Sf21	M1nINWZ2dmO2aX;uJIF{e2G7		NYW2dINOPjBibXnudy=>		NULDVoJsUW6qaXLpeIlwdiCxZjDmeYxtKGynbnf0bEBpfW2jbjDy[YNwdWKrbnHueEBENXSncn3pcoFtKE[OQVetTIl{NXSjZ3fl[EBJTEGFMTCoNUB1dyB2OEKgdoV{cWS3ZYOpJIV5eHKnc4Pl[EBqdiCVZkKxJINmdGy\|IIXzbY5oKFKKSz3LLGFkMS2DTVOgZZMhe3Wkc4TyZZRmKGmwY4XiZZRm\CCob4KgOlAhdWmwczDifUBndHWxcnXzZ4Vv[2ViYYPzZZktKEmFNUCgQUAxNjByNkW3OEDPxE1w	M4nGOFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ5ME[wO\|Y1Lz5{N{C2NFc3PDxxYU6=
insect cell	MnfTSpVv[3Srb36gZZN{[Xl?		NXvXUHlEPjBibXnudy=>		M{nENGlvcGmkaYTpc44hd2ZiZoXscEBt\W6pdHigbJVu[W5icnXjc41jcW6jboSgR{11\XKvaX7hcEBIW1RvdHHn[4VlKEiGQVOyJEgyKHSxIES4PEBz\XOrZIXld{kh\XiycnXzd4VlKGmwIHnud4VkfCClZXzsd{B2e2mwZzDSTGsuUyiDYzmtRW1EKGG\|IIP1ZpN1emG2ZTDpcoN2[mG2ZXSg[o9zKDZyIH3pcpMh[nliZnz1c5Jme2OnbnPlJIF{e2G7LDDJR\|UxKD1iMD6wNVA2OSEQvF2u	M{\JXFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ5ME[wO\|Y1Lz5{N{C2NFc3PDxxYU6=
insect cell	MXrGeY5kfGmxbjDhd5NigQ>?		MmD2OlAhdWmwcx?=		M1vtS2lvcGmkaYTpc44hd2ZiZoXscEBt\W6pdHigbJVu[W5icnXjc41jcW6jboSgR{11\XKvaX7hcEBJcXNvdHHn[4VlKEiGQVOzJEgyKHSxIESyPEBz\XOrZIXld{kwcHWvYX6gdoVkd22kaX7hcpQhVi22ZYLtbY5idCCJU2SteIFo\2WmIF7DU3IzKGW6cILld5Nm\CCrbjDpcpNm[3RiY3XscJMhfXOrbnegVmhMNUtqQXOpMWFOSyCjczDzeYJ{fHKjdHWgbY5kfWKjdHXkJIZweiB4MDDtbY5{KGK7IH\seY9z\XOlZX7j[UBie3OjeTygTWM2OCB;IECuNFEyODdizszNMi=>	M1zTcVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ5ME[wO\|Y1Lz5{N{C2NFc3PDxxYU6=
insect cell	NE\Cb4JHfW6ldHnvckBie3OjeR?=				MnrJTY5pcWKrdHnvckBw\iCqdX3hckBz\WOxbXLpcoFvfCCQLYTldo1qdmGuIFjpd{11[WepZXSgTGRCSzFzIDixJJRwKDN2NzDy[ZNq\HWnczmg[ZhxemW\|c3XkJIlvKGmwc3XjeEBk\Wyucz;iZYN2dG:4aYL1d{BmgHC{ZYPzbY9vKHO7c4TlcUB2e2mwZzDSTGsuUyiDYzmtRW1EKGG\|IIP1ZpN1emG2ZTDifUBndHWxcnXzZ4Vv[2ViYYPzZZktKEmFNUCgQUAxNjBzMUO3JO69VS5?	NFq1c5c9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{N{C2NFc3PCd-MkewOlA4PjR:L3G+
insect cell	Mk\rSpVv[3Srb36gZZN{[Xl?		M3\reVYxKG2rboO=		Mn7RTY5pcWKrdHnvckBw\iCqdX3hckBz\WOxbXLpcoFvfCCFLYTldo1qdmGuIFjpd{11[WepZXSgTGRCSzhiKEGgeI8hOzd5IILld4llfWW\|KTDlfJBz\XO\|ZXSgbY4hcW6\|ZXP0JINmdGy\|IIXzbY5oKFKKSz3LLGFkMS2NKFHjLU1CVUNiYYOgd5Vje3S{YYTlJIlv[3WkYYTl[EBnd3JiNkCgcYlveyCkeTDmcJVwemW\|Y3XuZ4Uh[XO\|YYmsJGlEPTBiPTCwMlMxPzRizszNMi=>	MkflQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjdyNkC3OlQoRjJ5ME[wO\|Y1RC:jPh?=
SHSY5Y	MkG4SpVv[3Srb36gZZN{[Xl?		M1HBXVghcHK\|		MVXJcohq[mm2aX;uJI9nKEiGQVO2JIlvKGi3bXHuJHNJW1l3WTDj[YxteyC3c3nu[{BDSVSFUDDhd{B{fWK\|dILheIUh[W[2ZYKgPEBpenNiYomgWWhRVENvRWPJMW1UN02VIHHuZYx6e2m\|LDDJR\|UxKD1iMD6wNFc5KM7:TT6=	M2TsNVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ5NkWwPVI2Lz5{N{[1NFkzPTxxYU6=
SHSY5Y	MlXjSpVv[3Srb36gZZN{[Xl?		MlywPEBpenN?		MmXPTY5pcWKrdHnvckBw\iCKRFHDJIlvKGi3bXHuJHNJW1l3WTDj[YxteyC3c3nu[{BOSUxiYYOgd5Vje3S{YYTlJIFnfGW{IEigbJJ{KGK7IGXIVGxENUWVST3NV{9OWyCjbnHsfZNqeyxiSVO1NEA:KDBwMEC5NUDPxE1w	MofUQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjd4NUC5NlUoRjJ5NkWwPVI2RC:jPh?=
Sf9	Mn64SpVv[3Srb36gZZN{[Xl?		MV20JIhzew>?		MkLwTY5pcWKrdHnvckBw\iCqdX3hckBz\WOxbXLpcoFvfCCJU2SteIFo\2WmIFjERWMyKGW6cILld5Nm\CCrbjDiZYN2dG:4aYL1d{Bqdm[nY4Tl[EBU\jliaX7z[YN1KGOnbHzzJJV{cW6pIF3PR3BCSyCjczDzeYJ{fHKjdHWgZYZ1\XJiNDDodpMh[nliVVjQUGMuTVOLLV3TM21UKGGwYXz5d4l{NCCLQ{WwJF0hOC5yMUW3JO69VS5?	MVy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPzZ3MEmyOUc,Ojd4NUC5NlU9N2F-
insect cell	M4fYSGZ2dmO2aX;uJIF{e2G7		NGPZZXM1KGi{cx?=		MoXuTY5pcWKrdHnvckBw\iCqdX3hckBz\WOxbXLpcoFvfCCKRFHDOkBmgHC{ZYPz[YQhcW5iYnHjeYxwfmm{dYOgbY5n\WO2ZXSgbY5{\WO2IHPlcIx{KHW\|aX7nJGJCXEOSIHHzJJN2[nO2cnH0[UBi\nSncjC0JIhzeyCkeTDVTHBNSy2HU1mtUXMwVVNiYX7hcJl{cXNuIFnDOVAhRSByLkCxOkDPxE1w	NU\5NGxqRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMke2OVA6OjVpPkK3OlUxQTJ3PD;hQi=>
SHSY5Y	M{fvc2Z2dmO2aX;uJIF{e2G7		M4PGcFghcHK\|		NFLtbnJKdmirYnn0bY9vKG:oIFjERWMyKGmwIHj1cYFvKFOKU2m1XUBk\WyuczD1d4lv\yCPT1PQRWMh[XNic4Xid5Rz[XSnIHHmeIVzKDhiaILzJIJ6KFWKUFzDMWVUUS2PUz;NV{BidmGueYPpd{whUUN3MDC9JFAvODF6ODFOwG0v	NWTkNZhFRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMke2OVA6OjVpPkK3OlUxQTJ3PD;hQi=>
HEK293T	NX\Me25xTnWwY4Tpc44h[XO\|YYm=		MWGzNEBucW6\|		NFn0OWlKdmirYnn0bY9vKG:oIILlZ49u[mmwYX70JIh2dWGwIFjERWMyKGW6cILld5Nm\CCrbjDISWszQTOWIHPlcIx{KHW\|aX7nJGFkNUuJTFfLLGFkMS2PQ1GgZZMhe3Wkc4TyZZRmKGGodHXyJFMxKG2rboOgbY4heHKnc3XuZ4Uhd2ZiRGTUJIJ6KG[udX;y[ZNk\W6lZTDhd5NigSxiSVO1NEA:KDBwMEG5JO69VS5?	NHzZTpg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUWxPVYxPCd-Mkm1NVk3ODR:L3G+
HEK293T	NH3hN4xHfW6ldHnvckBie3OjeR?=		MUSzNEBucW6\|		MljCTY5pcWKrdHnvckBw\iC{ZXPvcYJqdmGwdDDtc5V{\SCKRFHDOkBmgHC{ZYPz[YQhcW5iSFXLNlk{XCClZXzsd{Bkdy2neIDy[ZN{cW6pIH3veZNmKEiGQUKgeZNqdmdiQXOtT2dNT0tqQXOpMW1ESSCjczDzeYJ{fHKjdHWgZYZ1\XJiM{CgcYlveyCrbjDwdoV{\W6lZTDv[kBFXFRiYomg[ox2d3Knc3PlcoNmKGG\|c3H5MEBKSzVyIE2gNE4xOjhizszNMi=>	M2DocVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NUG5OlA1Lz5{OUWxPVYxPDxxYU6=
NFF	NEPSOHdEgXSxdH;4bYNqfHliYYPzZZk>				NVXhT4ZiS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hVk[IIHPlcIx{NCCLQ{WwJF0hOC5{IN88UU4>	M3LNelxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzNyMkS1OFAzLz5\|MEK0OVQxOjxxYU6=
insect cell	M4rSXWZ2dmO2aX;uJIF{e2G7				NFnnfWpKdmirYnn0bY9vKG:oIF6teIVzdWmwYXygS3NVNXSjZ3fl[EBz\WOxbXLpcoFvfCCqdX3hckBJTEGFNjDlfJBz\XO\|ZXSgbY4h[mGldXzveolzfXNiaX7m[YN1\WRiaX7z[YN1KGOnbHzzJJV{cW6pIGLIT2spSWNrQV3DJIF{KHO3YoP0doF1\SCkeTDmcJVwemW\|Y3XuZ4Uu[mG\|ZXSgZZN{[XluIFnDOVAhRSByLkCwPFUh\|ryPLh?=	NULvXpk{RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxM{CzOlU5QTJpPkOwN\|Y2QDl{PD;hQi=>
Sf21	M3\xXGZ2dmO2aX;uJIF{e2G7				MVHJcohq[mm2aX;uJI9nKENvdHXycYlv[WxiRlzBS{1JcXNvdHHn[4VlKG[3bHygcIVv\3SqIILlZ49u[mmwYX70JIh2dWGwIFjERWMyKGW6cILld5Nm\CCrbjDT[lIyKGmwc3XjeEBk\WyuczD1d4lv\yCUSFvLLGFkMUGPQzDhd{B{fWK\|dILheIUh[nliZnz1c5Jme2OnbnPlMYJie2WmIHHzd4F6NCCLQ{WwJF0hOC5yMEm0JO69VS5?	MXK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8{ODN4NUi5Nkc,OzB\|NkW4PVI9N2F-
insect cell	M2P0OmZ2dmO2aX;uJIF{e2G7				NHfiW2ZKdmirYnn0bY9vKG:oIILlZ49u[mmwYX70JIh2dWGwIFjERWM{N06FT2KyJIV5eHKnc4Pl[EBqdiCkYXP1cI93cXK3czDpcoZm[3SnZDDpcpNm[3RiY3XscJMhfXOrbnegVmhMUyiDYznBUWMh[XNic4Xid5Rz[XSnIHL5JIZtfW:{ZYPj[Y5k\S2kYYPl[EBie3OjeTygTWM2OCB;IECuNFEzPyEQvF2u	MVe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8{ODN4NUi5Nkc,OzB\|NkW4PVI9N2F-
insect cell	NFTVRYtHfW6ldHnvckBie3OjeR?=				MXjJcohq[mm2aX;uJI9nKENvdHXycYlv[WxiR2PUMZRi\2enZDDy[YNwdWKrbnHueEBpfW2jbjDISGFEOiCneIDy[ZN{\WRiaX6gZoFkfWyxdnnyeZMhcW6oZXP0[YQhcW6\|ZXP0JINmdGy\|IIXzbY5oKFKKS1uoRYMqSU2FIHHzJJN2[nO2cnH0[UBjgSCobIXvdoV{[2WwY3WtZoF{\WRiYYPzZZktKEmFNUCgQUAxNjB{Nkeg{txONg>?	M3PndFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzNyM{[1PFkzLz5\|MEO2OVg6OjxxYU6=
insect cell	M{X6NmZ2dmO2aX;uJIF{e2G7				NGfLSYtKdmirYnn0bY9vKG:oIFOteIVzdWmwYXygTIl{NXSjZ3fl[EBz\WOxbXLpcoFvfCCqdX3hckBJTEGFODDlfJBz\XO\|ZXSgbY4h[mGldXzveolzfXNiaX7m[YN1\WRiaX7z[YN1KGOnbHzzJJV{cW6pIGLIT2spSWNrQV3DJIF{KHO3YoP0doF1\SCkeTDmcJVwemW\|Y3XuZ4Uu[mG\|ZXSgZZN{[XluIFnDOVAhRSByLk[wPUDPxE1w	MkDhQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOzB\|NkW4PVIoRjNyM{[1PFkzRC:jPh?=
A20	MmrDSpVv[3Srb36gZZN{[Xl?				MUTCbY5lcW6pIHHm[olvcXS7IITve4Fz\HNiSFTBR\|EhMEirc4TvcoUh\GWjY3X0fYxie2ViMTmgbY4hdW:3c3WgRVIxKGOnbHzzMEBmgHC{ZYPz[YQh[XNiYnnu[Ilv\yClb37zeIFvfCBqcFvpLUwhU2liPTCwMlAxOTB5MjFOwG0v	NW\tUWRPRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUG5OlA1QDlpPkGxPVYxPDh7PD;hQi=>
Hela	NUL3RWR3TnWwY4Tpc44h[XO\|YYm=				NX;BdmU2UW6qaXLpeIlwdiCxZjDISGFEKGmwIHj1cYFvKEinbHGgZ4VtdHNiboXjcIVieiCneITyZYN1eyCkeTDmcJVwemmvZYTybYMh[XO\|YYmsJGtqKD1iMD61NFQh\|ryPLh?=	MW[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTV{MEW4NEc,OTl3MkC1PFA9N2F-
Sf9	NWLYXWFUTnWwY4Tpc44h[XO\|YYm=		NG\yVXc6OCCvaX7z		NFS5bWxKdmirYnn0bY9vKG:oIH\1cIwhdGWwZ4ToJJJm[2:vYnnuZY51KGi3bXHuJG4ufGW{bXnuZYwhT1OWLYTh[4dm\CCKRFHDOkBmgHC{ZYPz[YQhcW5iYnHjeYxwfmm{dYOtbY5n\WO2ZXSgV4Y6KGmwc3XjeEBk\WyuczD1d4lv\yCUSFvLLGFkMUGPQzDhd{B{fWK\|dILheIUh[W[2ZYKgPVAhdWmwczDifUBndHWxcnnt[ZRmeixiS3mgQUAxNjByMEW4JO69VS5?	NVTXVVY3RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm1PFk1PDFpPkK5OVg6PDRzPD;hQi=>
Sf21	M1rFTWZ2dmO2aX;uJIF{e2G7		MkXQOlAhdWmwcx?=		MUHJcohq[mm2aX;uJI9nKHKnY3;tZolv[W62IHj1cYFvKENvdHXycYlv[WxiRlzBS{9JcXNvdHHn[4VlKEiGQVOxJIV5eHKnc4Pl[EBqdiCkYXP1cI93cXK3cz3pcoZm[3SnZDDT[lIyKGmwc3XjeEBk\WyuczD1d4lv\yCUSFvLLGFkMUGPQzDhd{B{fWK\|dILheIUh[W[2ZYKgOlAhdWmwczDifUBndHWxcnnt[ZRmeixiS3mgQUAxNjByME[0JO69VS5?	M1rtVlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NUi5OFQyLz5{OUW4PVQ1OTxxYU6=
insect cell	MXXGeY5kfGmxbjDhd5NigQ>?		M1\yTlYxKG2rboO=		NYHrOlYxUW6qaXLpeIlwdiCxZjDmeYxtKGynbnf0bEBz\WOxbXLpcoFvfCCqdX3hckBENXSncn3pcoFtKEircz30ZYdo\WRiSFTBR\|MwVi22ZYLtbY5idCCJU2SteIFo\2WmIILlZ49u[mmwYX70JIh2dWGwIF7DU3IzKCh\|OUWgeI8hPDh7IILld4llfWW\|KTDlfJBz\XO\|ZXSgbY4h[mGldXzveolzfXNvaX7m[YN1\WRiaX7z[YN1KGOnbHzzJJV{cW6pIGLIT2spSWNrQV3DJIF{KHO3YoP0doF1\SCjZoTldkA3OCCvaX7zJIJ6KG[udX;ybY1mfGW{LDDLbUA:KDBwMECwPFQh\|ryPLh?=	NF;IXos9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUW4PVQ1OSd-Mkm1PFk1PDF:L3G+
insect cell	MXzGeY5kfGmxbjDhd5NigQ>?		MnvjOlAhdWmwcx?=		NEDk[\|hKdmirYnn0bY9vKG:oIH\1cIwhdGWwZ4ToJJJm[2:vYnnuZY51KGi3bXHuJGMufGW{bXnuZYwhT1OWLYTh[4dm\CCKRFHDNkBmgHC{ZYPz[YQhcW5iYnHjeYxwfmm{dYOtbY5n\WO2ZXSgbY5{\WO2IHPlcIx{KHW\|aX7nJHJJU0tqQXOpRW1EKGG\|IIP1ZpN1emG2ZTDh[pRmeiB4MDDtbY5{KGK7IH\seY9zcW2ndHXyMEBMcSB;IECuNFA{PTVizszNMi=>	MVS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTV6OUS0NUc,Ojl3OEm0OFE9N2F-
insect cell	MXjGeY5kfGmxbjDhd5NigQ>?				NX:2OJlsUW6qaXLpeIlwdiCxZjDy[YNwdWKrbnHueEBpfW2jbjDISGFEOTBiZYjwdoV{e2WmIHnuJIJi[3Wub4\pdpV{NWmwZnXjeIVlKGmwc3XjeEBk\WyuczD1d4lv\yCobIXvdo9o\W6rYzDw[ZB1cWSnIGLIT2tC[yCjczDzeYJ{fHKjdHWgZpkh\my3b4LpcYV1\XJuIFvpJF0hOC5yMES3OkDPxE1w	MUG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTV6OUS0NUc,Ojl3OEm0OFE9N2F-
insect cell	NFj5NXFHfW6ldHnvckBie3OjeR?=		NYjWU41VPjBibXnudy=>		MlLjTY5pcWKrdHnvckBw\iC{ZXPvcYJqdmGwdDDoeY1idiCFLYTldo1qdmGuIFjpd{11[WepZXSgTGRCSzhiKEGgeI8hOzd5IILld4llfWW\|KTDlfJBz\XO\|ZXSgbY4h[mGldXzveolzfXNvaX7m[YN1\WRiaX7z[YN1KGOnbHzzJJV{cW6pIGLIT{hC[ymNKFHjLWFOSyCjczDzeYJ{fHKjdHWgZYZ1\XJiNkCgcYlveyCkeTDmcJVwemmvZYTldkwhU2liPTCwMlE1PSEQvF2u	NVW1[4lxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm1PFk1PDFpPkK5OVg6PDRzPD;hQi=>
insect cell	M{fJWmZ2dmO2aX;uJIF{e2G7				NX\4VpJMUW6qaXLpeIlwdiCxZjDy[YNwdWKrbnHueEBpfW2jbjDOMZRmem2rbnHsJGhqey22YXfn[YQhUESDQ{GxJEgyKHSxIEO0O{Bz\XOrZIXld{kh\XiycnXzd4VlKGmwIHLhZ5Vtd3[rcoXzMYlv\mWldHXkJIlve2WldDDj[YxteyC3c3nu[{BTUEuNKFHjLWFOSyCjczDzeYJ{fHKjdHWgZpkh\my3b4LpcYV1\XJuIFvpJF0hOC52MEGg{txONg>?	MXS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTV6OUS0NUc,Ojl3OEm0OFE9N2F-
GM15850	MXnGeY5kfGmxbjDhd5NigQ>?	MlTONE4yKHWP	NXK4eFNtOTJiaILz		M4XW[mlvcGmkaYTpc44hd2ZiSFTBR{BqdiCqdX3hckBIVTF3OEWwJINmdGy\|IHHzd4V{e2WmIHHzJIlv[3KnYYPlJIlvKHSxdHHsJIFk\XS7bHH0[YQhcGm\|dH;u[UBt\X[nbDDheEAxNjFidV2gZYZ1\XJiMUKgbJJ{KGK7IGfld5Rmem5iYnzveEBidmGueYPpdy=>	NFW4RVQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zNkmyNVM3Pyd-MU[5NlE{Pjd:L3G+
A549	MULGeY5kfGmxbjDhd5NigQ>?	MmW4NE4yKHWP			NF2wSY9KdmirYnn0bY9vKG:oIGPJVnQzKGmwIFG1OFkh[2WubIOgZZN{\XO\|ZXSgZZMh[WKrbHn0fUB1dyCrbnT1Z4UhcHmyZYLhZ4V1gWyjdHnvckBw\iC2dXL1cIlvKGK7IGfld5Rmem5iYnzveEBidmGueYPpd{BifCByLkGgeW0>	M1nP[lxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF5MUS5PFYxLz5zN{G0PVg3ODxxYU6=
ST14A	NX3ITpVQTnWwY4Tpc44h[XO\|YYm=	MXq3OUBvVQ>?			M{HnXGlv\HWldHnvckBw\iCURWPUM25TW0ZvY3;1dIxm\CC{ZYDy[ZN{cW:wIH;mJIx2[2moZYLhd4UhfGGpZ3XkJJJifCCURUGvUnJUTSCERF7GJJBzd22xdHXyJIFkfGm4aYT5JIV5eHKnc4Pl[EBqdiCVVEG0RUBk\WyuczDheEA4PSCwTTDhd5Nme3OnZDDhd{BqdmO{ZXHz[UBqdiCudXPp[oVz[XOnIHHjeIl3cXS7	MWK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPzV4NUm5N{c,OTd3NkW5PVM9N2F-
HEK293	M3vOOWZ2dmO2aX;uJIF{e2G7	Mn3HOlAxKG6P			NF3mSnhKdmO{ZXHz[UBqdiCJUmC3PEBxem:2ZXnuJIxmfmWuIHnuJGhGUzJ7MzDj[YxteyCjdDC2NFAhdk1iYomgbY1ufW6xYnzveC=>	M{XYVlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF5NU[2O\|MzLz5zN{W2Olc{OjxxYU6=
HEK293	NUOwc3FDTnWwY4Tpc44h[XO\|YYm=	MWS2NFAhdk1?			MoHpTY5kemWjc3WgbY4heHKxdHXpckBlcXO3bH\p[IUhcXOxbXXyZZNmKGyndnXsJIlvKEiHS{K5N{Bk\WyuczDheEA3ODBibl2gZpkhcW2vdX7vZoxwfA>?	NEPme5U9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zN{W2Olc{Oid-MUe1OlY4OzJ:L3G+
HeLa	MmrMSpVv[3Srb36gZZN{[Xl?	MVixJJVO	NX;odGtqOjRiaILz		M{DtO2lv\HWldHnvckBw\iCyMU[g[ZhxemW\|c3nvckBqdiCqdX3hckBJ\UyjIHPlcIx{KGG2IEGgeW0h[W[2ZYKgNlQhcHK\|IHL5JHdme3Sncn6gZoxwfHSrbne=	MVW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPzZ2M{GxNUc,OTd4NEOxNVE9N2F-
HeLa	NIHYS\|VHfW6ldHnvckBie3OjeR?=	NITudlgyKHWP	NGXrS2YzPCCqcoO=		Mnr0TY5lfWO2aX;uJI9nKHB{NzDlfJBz\XO\|aX;uJIlvKGi3bXHuJGhmVGFiY3XscJMh[XRiMTD1UUBi\nSncjCyOEBpenNiYomgW4V{fGW{bjDicI91fGmwZx?=	M1v5UFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF5NkSzNVEyLz5zN{[0N\|EyOTxxYU6=
HeLa	MkLuSpVv[3Srb36gZZN{[Xl?	NH\XNogyKHWP	MVuyOEBpenN?		M2fJTmlv\HWldHnvckBw\iCyMkGg[ZhxemW\|c3nvckBqdiCqdX3hckBJ\UyjIHPlcIx{KGG2IEGgeW0h[W[2ZYKgNlQhcHK\|IHL5JHdme3Sncn6gZoxwfHSrbne=	M3yxO\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF5NkSzNVEyLz5zN{[0N\|EyOTxxYU6=
HCT116	NGr6bXhHfW6ldHnvckBie3OjeR?=				NF;MeWlKdmirYnn0bY9vKG:oIHj1cYFvKEiGQVOxJIF{e2W\|c3XkJIF{KGirc4TvcoUhcHmyZYLhZ4V1gWyjdHnvckBqdiCqdX3hckBJS1RzMU[gZ4VtdHNiYomgW4V{fGW{bjDicI91	MVK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQDB3NEKzPUc,OThyNUSyN\|k9N2F-
HCT116	M{T1VmZ2dmO2aX;uJIF{e2G7				MmOxTY5pcWKrdHnvckBw\iCqdX3hckBJTEGFNjDhd5Nme3OnZDDhd{B1fWK3bHnuJIh6eGW{YXPleJlt[XSrb36gbY4hcHWvYX6gTGNVOTF4IHPlcIx{KGK7IGfld5Rmem5iYnzveC=>	NYH1OVduRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUiwOVQzOzlpPkG4NFU1OjN7PD;hQi=>
HEK293 STF	NWruZZJKTnWwY4Tpc44h[XO\|YYm=		MnLoNlQhcHK\|		MWHBZ5RqfmG2aX;uJI9nKG2xdYPlJHdvfDOjIIPp[45idGmwZzDlfJBz\XO\|ZXSgbY4hUEWNMkmzJHNVTiClZXzsd{Bie3Onc4Pl[EBieyCrbnPy[YF{\SCrbjD0doFve2O{aYD0bY9v[WxiYXP0bZZqfHliYX\0[ZIhOjRiaILzJIJ6KGy3Y3nm[ZJie2VicnXwc5J1\XJiZ3Xu[U1j[XOnZDDsZYN1[XSnIHTlbJllem:pZX7hd4Uh[XO\|YYm=	MUe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTB{Mk[3OUc,OTlyMkK2O\|U9N2F-
NCI-H661	NVXUXpZZTnWwY4Tpc44h[XO\|YYm=	NWDhd2U1OzByIH7N	MnWxOkBpenN?		MUHJcohq[mm2aX;uJI9nKEiGQVOgbY4hcHWvYX6gUmNKNUh4NkGgZ4VtdHNiYYPz[ZN{\WRiYYOgbY5lfWO2aX;uJI9nKGirc4TvcoUhUDRiYXPleJlt[XSrb36gZZQhOzByIH7NJIFnfGW{IE[gbJJ{KGK7IGfld5Rmem5iYnzveEBidmGueYPpdy=>	MnXPQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTl\|OEW2NFAoRjF7M{i1OlAxRC:jPh?=
NCI-H661	NWn2bXJbTnWwY4Tpc44h[XO\|YYm=	NHP3fJc{ODBibl2=	NVrQSI51PiCqcoO=		NYnjNWo6UW6qaXLpeIlwdiCxZjDISGFEKGmwIHj1cYFvKE6FST3IOlYyKGOnbHzzJIF{e2W\|c3XkJIF{KGmwZIXjeIlwdiCxZjDhcJBp[S22dXL1cIlvKGGlZYT5cIF1cW:wIHH0JFMxOCCwTTDh[pRmeiB4IHjyd{BjgSCZZYP0[ZJvKGKub4SgZY5idHm\|aYO=	NHXnd4Q9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOUO4OVYxOCd-MUmzPFU3ODB:L3G+
HL60	NGLUSI5HfW6ldHnvckBie3OjeR?=	MkfuNlAhfWdxbXy=	NUDaWWNyOjRiaILz		M{DReWlvcGmkaYTpc44hd2ZiSFTBR{BqdiCqdX3hckBJVDZyIHPlcIx{KGG\|c3Xzd4VlKGG\|IHnuZ5Jm[XOnIHnuJIhqe3SxbnWgTFMh[WOndInsZZRqd25iYYSgNlAhfWdxbXygZYZ1\XJiMkSgbJJ{KGK7IGfld5Rmem5iYnzveEBidmGueYPpdy=>	M17YSFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7NUO0OFcyLz5zOUWzOFQ4OTxxYU6=
primary bronchial epithelial cell	MUHGeY5kfGmxbjDhd5NigQ>?	M{jjSFAvOSC3TR?=			NXHqXWhDUW6qaXLpeIlwdiCxZjDISGFEPyCrbjDoeY1idiCycnntZZJ6KGK{b37jbIlidCCncHn0bIVtcWGuIHPlcIx{KGG\|c3Xzd4VlKGG\|IHnu[JVkfGmxbjDv[kBufXSjboSgSoRmdHSjNUC4JGNHXFJicILveIVqdiCjcHnjZYwhe3W{ZnHj[UBtd2OjbHn6ZZRqd25iYYSgNE4yKHWP	M3TRcFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7OU[2O\|g6Lz5zOUm2Olc5QTxxYU6=
MCF7	M3vCS2Z2dmO2aX;uJIF{e2G7	M3zmeFAvOSC3TR?=	NU\ubY1WOTZiaILz		M2XsfWlvcGmkaYTpc44hd2ZiU1nSWFIhcW5iaIXtZY4hVUOINzDj[YxteyCjc4Pld5Nm\CCjczD0eYJ2dGmwIHj5dIVz[WOndInsZZRqd25iYYSgNE4yKHWPIHHmeIVzKDF4IHjyd{BjgSCZZYP0[ZJvKGKub4S=	M2PYSVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJyMEOwN\|Q{Lz5{MECzNFM1OzxxYU6=
HeLa	NUnuRnRCTnWwY4Tpc44h[XO\|YYm=	MmO2NUB2VQ>?	NXnyclE4OTBibXnudy=>		MWrJcohq[mm2aX;uJI9nKEiGQVOgbY4hcHWvYX6gTIVN[SClZXzsd{BifCBzIIXNJIFnfGW{IEGwJI1qdnNiYomg[ox2d3KxbXX0dolkKGG\|c3H5	M2nieFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzMEW1PFQ5Lz5{MUC1OVg1QDxxYU6=
MCF7	MWPGeY5kfGmxbjDhd5NigQ>?	MYewMlUhfU1?	NUW1Z2pUOjRiaILz		MmKyTY5pcWKrdHnvckBw\iCFbHHzd{AyKGirc4TvcoUh\GWjY3X0fYxie2ViaX6gbJVu[W5iTVPGO{Bk\WyuczDhd5Nme3OnZDDhd{B2eC2{ZXf1cIF1cW:wIH;mJJAzOSCycn;0[YlvKGyndnXsJIF1KDBwNTD1UUBi\nSncjCyOEBpenNiYomgW4V{fGW{bjDicI91KGGwYXz5d4l{	M4fWRVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{MkiwN\|Y{Lz5{MkK4NFM3OzxxYU6=
MCF7	MlewSpVv[3Srb36gZZN{[Xl?	M17ySFAvPSC3TR?=	M{LKbFI1KGi{cx?=		MofCTY5pcWKrdHnvckBw\iCKRFHDOkBqdiCqdX3hckBOS0Z5IHPlcIx{KGG\|c3Xzd4VlKGG\|IHPoZY5o\SCrbjD0eYJ2dGmwIHHj[ZR6dGG2aX;uJIxmfmWuIHH0JFAvPSC3TTDh[pRmeiB{NDDodpMh[nliV3XzeIVzdiCkbH;0JIFv[Wy7c3nz	Mnf4QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJ{OECzOlMoRjJ{MkiwN\|Y{RC:jPh?=
MCF7	M2W4eGZ2dmO2aX;uJIF{e2G7	M1q1dVAvPSC3TR?=	NXX6WGhqOjRiaILz		MoTrTY5pcWKrdHnvckBw\iCKRFHDNUBqdiCqdX3hckBOS0Z5IHPlcIx{KGG\|c3Xzd4VlKGG\|IIXwMZJm\3WuYYTpc44hd2ZiYXPleJlt[XSnZDDobZN1d26nIFizJJBzd3SnaX6gcIV3\WxiYYSgNE42KHWPIHHmeIVzKDJ2IHjyd{BjgSCZZYP0[ZJvKGKub4SgZY5idHm\|aYO=	NYnlUGNsRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkKyPFA{PjNpPkKyNlgxOzZ\|PD;hQi=>
PC12	NVvOfXlkTnWwY4Tpc44h[XO\|YYm=	NFXyXIIyOCC3TR?=	MXW0PEBpenN?		M1v1U2lvcGmkaYTpc44hd2ZiSFTBR\|YhcW5icnH0JHBEOTJiY3XscJMh[XO\|ZYPz[YQh[XNiYXPleJlt[XSrb36gc4YhcGm\|dH;u[UBJOyCjdDCxNEB2VSCjZoTldkA1QCCqcoOgZpkhX2W\|dHXyckBjdG:2dHnu[{BidmGueYPpdy=>	MlGwQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN7MEW2PFAoRjJ\|OUC1OlgxRC:jPh?=
PC12	MW\GeY5kfGmxbjDhd5NigQ>?	M3Lt[VExKHWP	MXW0PEBpenN?		MUDJcohq[mm2aX;uJI9nKEiGQVO2JIlvKHKjdDDQR\|EzKGOnbHzzJIF{e2W\|c3XkJIF{KGmwZIXjeIlwdiCxZjDhcJBp[S22dXL1cIlvKGGlZYT5cIF1cW:wIHH0JFExKHWPIHHmeIVzKDR6IHjyd{BjgSCZZYP0[ZJvKGKub4T0bY5oKGGwYXz5d4l{	Ml7OQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN7MEW2PFAoRjJ\|OUC1OlgxRC:jPh?=
PC12	NYjre5R6TnWwY4Tpc44h[XO\|YYm=	M1rj[\|ExKHWP	MkfvOUBl[Xm\|		NHXzWWNKdmS3Y4Tpc44hd2ZibnX1dol1\SCxdYTndo94fGhiaX6gdoF1KFCFMUKgZ4VtdHNiYYSgNVAhfU1iYX\0[ZIhPSCmYYnz	MnnMQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN7MEW2PFAoRjJ\|OUC1OlgxRC:jPh?=
SH-SY5Y	NWHBW217TnWwY4Tpc44h[XO\|YYm=	MVexNEB2VQ>?	M4nkc\|Uh\GG7cx?=		MUDJcoR2[3Srb36gc4YhdmW3cnn0[UBwfXSpcn;3eIghcW5iaIXtZY4hW0hvU2m1XUBk\WyuczDheEAyOCC3TTDh[pRmeiB3IHThfZM>	M2XqVVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ\|OUC1OlgxLz5{M{mwOVY5ODxxYU6=
A549	Mnv6RY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl?	NVXRRnZROC52IIXN	MViyOEBpenN?		MkPZRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6\|dDDoeY1idiCDNUS5JINmdGy\|IHHzd4V{e2WmIHHzJJNpenWwa3XuJIFv\CC\|aHHydEB{cGGyZTDheEAxNjRidV2gZYZ1\XJiMkSgbJJ{KGK7IIDoZZNmKGOxboTyZZN1KG2rY4Lvd4NweHl?	NWnH[5RXRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW4PFQyOTJpPkK1PFg1OTF{PD;hQi=>
HeLa	M1nuU2Z2dmO2aX;uJIF{e2G7				NVrj[nl2UW6qaXLpeIlwdiCxZjDISGFEPiCrbjDoeY1idiCKZVzhJINmdGy\|IHHzd4V{e2WmIHHzJJR2[nWuaX6gZYNmfHmuYYTpc44hcW6ldXLheIVlKG[xcjDveoVzdmmpaISgZpkhcW2vdX7v[ox2d3Knc3PlcoNmKG2rY4Lvd4NweGmlIHHuZYx6e2m\|	NVn3TJBJRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMk[2NVE6OTlpPkK2OlEyQTF7PD;hQi=>
C127-LT	NF;MXXFHfW6ldHnvckBie3OjeR?=	NYDse3JuOjByIH7N	NEjpV5IzPCCqcoO=		M4nOZWlvcGmkaYTpc44hd2ZiSFTBR{BqdiCvb4Xz[UBEOTJ5LVzUJINmdGy\|IHHzd4V{e2WmIHHzJIFkfGm4YYTpc44hd2ZiRVfGVEBmgHC{ZYPzbY9vKGG2IEKwNEBvVSCjZoTldkAzPCCqcoOgZpkh\my3b4Lld4NmdmOnIH3pZ5Jwe2OxcIm=	NUTHbYRoRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMk[5PVY{PzJpPkK2PVk3Ozd{PD;hQi=>
HeLa nuclear	NVfvdVc1TnWwY4Tpc44h[XO\|YYm=	NGDwbmMyOCC2bzCyOUB2VQ>?	NVj5fow3OzBibXnudy=>		Ml6wR49ueGW2aYTpeoUhcW6qaXLpeIlwdiCxZjDISGFEKGmwIHj1cYFvKEinTHGgcpVkdGWjcjDj[YxteyCjdDCxNEB1dyB{NTD1UUB2e2mwZzDCc4Mu[WOndInsMYx6e2mwZT3BUWMh[XNic4Xid5Rz[XSnIHHmeIVzKDNyIH3pcpMh[nliTHnu[Zdm[X[ncj3CeZJsKHCub4SgZY5idHm\|aYO=	M13NNFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ4OUm2N\|czLz5{Nkm5OlM4OjxxYU6=
HeLa	MoPQSpVv[3Srb36gZZN{[Xl?	MXWyJJVO	MYmyOEBpenN?		NXm3Z3JiUW6qaXLpeIlwdiCxZjDISGFEOSCrbjDoeY1idiCKZVzhJINmdGy\|IHHzd4V{e2WmIHHzJIh6eGW{YXPleJlt[XSrb36gc4YhcGm\|dH;u[UBJOyCjdDCyJJVOKGmwY4XiZZRm\CCob4KgNlQhcHK\|IHL5JHdme3Sncn6gZoxwfCCjbnHsfZNqew>?	M1vwR\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ5ME[wO\|Y1Lz5{N{C2NFc3PDxxYU6=
HN13	NWC0VHJRTnWwY4Tpc44h[XO\|YYm=		NHz3eG4zPCCqcoO=		MljLTY5pcWKrdHnvckBw\iCKRFHDJIlvKGi3bXHuJGhPOTNiY3XscJMh[XO\|ZYPz[YQh[XNicnXkeYN1cW:wIHnuJIhqe3SxbnWgTFMhVHm\|OTDhZ4V1gWyjdHnvckBqdmO3YnH0[YQh\m:{IEK0JIhzeyCkeTDpcY12dm:obIXvdoV{[2WwY3WgZZN{[Xl?	MoTrQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjlyM{GwOlYoRjJ7MEOxNFY3RC:jPh?=
HeLaS3	Mmr0SpVv[3Srb36gZZN{[Xl?	NVLNcmhJOTBidV2=			MlziTY5pcWKrdHnvckBw\iCKRFHDJIlvKGi3bXHuJGhmVGGVMzDj[YxteyCjc4Pld5Nm\CCjczDpcoNz\WG\|ZTDpckBpcXO2b37lJGg{UzliYXPleJlt[XSrb36gZZQhOTBidV2gcYVie3W{ZXSgbY1u\WSrYYTlcJkh[nliaX3teY5w[myxdDDhcoFtgXOrcx?=	Ml3BQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOzB{NUi1N\|UoRjNyMkW4OVM2RC:jPh?=
HeLaS3	MnPzSpVv[3Srb36gZZN{[Xl?	M1fLelExKHWP	NEezcmoyPiCqcoO=		MYrJcohq[mm2aX;uJI9nKEiGQVOgbY4hcHWvYX6gTIVN[VN\|IHPlcIx{KGG\|c3Xzd4VlKGG\|IHnuZ5Jm[XOnIHnuJIhqe3SxbnWgTFNMQSCjY3X0fYxifGmxbjDheEAyOCC3TTD0doVifGWmIH\vdkAyPiCqcoOg[o9tdG:5ZXSgZpkh[2:vcH;1coQhf2G\|aH;1eEBidmRibXXhd5Vz\WRidYCgeI8hOjRiaILzJIJ6KGmvbYXuc4Jtd3RiYX7hcJl{cXN?	MXe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8{ODJ3OEWzOUc,OzB{NUi1N\|U9N2F-

... Click to View More Cell Line Experimental Data

Assay

Methods	Test Index	PMID
Western blot	EGFR / STAT3 ; PubMed: 31289542 Oncol Lett Expression of EGFR and STAT3 in PC3 cells treated with TSA. PC3 cells were plated in 6-cm dishes, and 0.25, 0.5 or 1 µM TSA was added for 24 h. DMSO was added into the control group wells. Cells were collected and lysed with lysis buffer and the protein expression analyzed via western blotting. Cyclin D1 / CDK6 / CDK4 / p-RB / RB; PubMed: 31289542 Oncol Lett Expression of cyclin D1, CDK6, CDK4 and RB, and the phosphorylation of RB, was detected in PC3 cells treated with TSA for 24 h. MMP-1 / MMP-3 / MMP-13 / TIMP-1; PubMed: 27431944 Mol Med Rep Chondrocytes were pretreated with increasing concentrations of TSA for 2 h, followed by stimulation with 5 ng/ml IL-1β for 24 h. Acetyl-H3 (Lys27) / H3 (96C10) / Acetyl-H4(Lys8) / H4(L64C1); PubMed: 27431944 Mol Med Rep Chondrocytes were treated with increasing concentrations of TSA for 24 h. α-H3Ac / α-H4Ac / α-H3K9Ac / α-H3K9 S10 / α-H3K4 me / α-H3K4 me2 / α-H3K9 me2; PubMed: 23802098 Front Oncol Histone acetylation occurs directly at the promoter region of IL-23R. The ChIP assay demonstrates that TSA treatment results in an increase in the acetylation of histone H3 and H4. A549 cells were cultured in the presence or absence of TSA (250 ng/mL) for a period of 24 h. Subsequently, a ChIP assay was performed using the following antibodies; pan acetyl-histone H3 (H3Ac), pan acetyl-histone H4 (H4Ac), acetyl-histone H3 Lys 9 (H3K9Ac), acetyl-histone H3 Lys 9/14 (H3K9/14ac), acetyl-histone H3 Lys 9 phosphoSer10 (H3K9S10), methyl-histone H3 Lys 4 (H3K4Me), di methyl-histone H3 Lys 4 (H3K4Me2), and di methyl-histone H3 Lys 9 (H3K9Me2). Input DNA serves as a positive control as recommended by the manufacturer (Diagenode). A no antibody control was included to test for non-specific binding (UT, untreated; TSA, Trichostatin A).	31289542 27431944 23802098
Immunofluorescence	α-C/EBPβ / α-HP1α ; PubMed: 21122806 Exp Cell Res 3T3-L1 preadipocytes were grown on coverslips for three days and induced to differentiate by treatment with MDI (48 h) in the presence of vehicle (-TSA) or 87 nM Trichostatin A (+TSA). Under these experimental conditions: A-H Cells were fixed and permeabilized in cold methanol, subjected to IIF with the indicated antibodies, and nuclei were counterstained with DAPI. Scale bar, 5 μm. α-HDAC1 ; PubMed: 29045501 PLoS One MCF-7 cells were treated with indicated concentrations of trichostatin A (optical sections E-H, respectively) for 12 hours, fixed, permeabilized and optical sections were obtained by laser scanning confocal microscopy. Fluorescence signal for HDAC1 is shown in green (left panels), DAPI staining is shown in blue (middle panels), and merged optical sections are shown in the right panels. α-tubulin / acetylated histone 3; PubMed: 27957719 Neurotherapeutics Immunocytochemistry for acetylated α-tubulin (red) and acetylated histone 3 (green) on N2a cells treated with 1 μM TSA, ACY-738, and ACY-775.	21122806 29045501 27957719
Growth inhibition assay	Cell viability (A549 cells); PubMed: 27571418 PLoS One Cytotoxicity of histamine determined by MTT assay in A549 cells. Cell viability (MDA-MB-231 cells); PubMed: 27548148 Int J Mol Sci The human breast cancer cells (MDA-MB-231) were incubated with various concentrations of TSA (0–300 nM) for 24 h. Cell viability was measured by WST-8. Cell viability (PC3 cells); PubMed: 31289542 Oncol Lett PC3 cells were plated in a 96-well plate and treated with different doses of TSA (0, 0.25, 0.5 and 1 µM) for 72 h; an MTT assay was used to measure the effects of TSA on PC3 cell proliferation.	27571418 27548148 31289542

体内研究

Administration of Trichostatin A 按 0.5 mg/kg 剂量处理N-甲基-N-亚硝基脲致癌物诱发的大鼠乳腺癌模型，持续处理4周，具有有效的抗癌活性，即使按按高达5 mg/kg剂量处理也没有任何可测量到的毒性。^[1]Trichostatin A 按10 mg/kg 剂量单独腹腔注射给药非转基因和脊髓性肌萎缩症（SMA）模型鼠，导致乙酰化的 H3 和 H4组蛋白水平提高，也导致活运动神经元(SMN) 基因表达稍微提高。Trichostatin A 每天按10 mg/kg剂量处理SMA模型鼠，促进存活, 减轻体重下降,且增强运动行为。^[5]

激酶实验：^[1]	- 合并体外HDAC活性 : 从每种乳腺癌细胞系(MCF-7, T-47D, ZR-75-1, BT-474, MDA-MB-231, MDA-MB-453, CAL 51,或 SK-BR-3)中准备全部细胞提取物。在溶于0.1% (v/v)乙醇的不同浓度Trichostatin A存在时，或者使用0.1% (v/v)乙醇作为对照, 20 μL 细胞粗提取物(~2.5 ×10⁵ 个细胞)与 1 μL ~1.5 × 10⁶ cpm [³H]乙酰标记的组蛋白 H4 肽底物(第2-20位NH2-末端残基) 在25^oC下温育60分钟。使用50 μL 1 M HCl/0.16 M 乙酸对每组 200-μL 反应进行淬火，然后使用600 μL 乙酸乙酯进行抽提，通过闪烁计数器测量释放的[³H]乙酸。使用非线性回归曲线拟合抑制数据，绘制合适的剂量反应曲线，而测定IC50。
细胞实验：^[1]	- 合并 Cell lines: MCF-7, T-47D, ZR-75-1, BT-474, MDA-MB-231, MDA-MB-453, CAL 51, 和 SK-BR-3 Concentrations: 溶于无水酒精,终浓度为~10 μM Incubation Time: 96小时 Method: 使用不同浓度Trichostatin A处理细胞96小时。处理后,使用sulforhodamine B 比色分析测定细胞增殖。通过台酚蓝染色排除法测定细胞活力。 (Only for Reference)
动物实验：^[1]	- 合并 Animal Models: 携带NMU诱导的肿瘤的近交系(Ludwig/Wistar/Olac)处女鼠 Dosages: ~5 mg/kg/day Administration: 皮下注射 (Only for Reference)

参考文献

- 合并

溶解度 (25°C)

体外	DMSO	23 mg/mL (76.05 mM)
	Water	Insoluble
	Ethanol	Insoluble
体内	从左到右依次将纯溶剂加入产品，现配现用(数据来自Selleck实验检测而非文献)： 2% DMSO+30% PEG 300+2% Tween 80+ddH2O	3mg/mL

* 溶解度检测是由Selleck技术部门检测的，可能会和文献中提供的溶解度有所差异，这是由于生产工艺和批次不同产生的正常现象。请按照顺序依次加入各个纯溶剂。

化学数据 Download Trichostatin A (TSA) SDF

分子量	302.4
化学式	C₁₇H₂₂N₂O₃
CAS号	58880-19-6
储存条件	3年-20°C 粉状 2年-80°C 溶于溶剂
别名	N/A

动物体内配方计算器 (澄清溶液)

第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量）

给药剂量

mg/kg

动物平均体重

每只动物给药体积

动物数量

只

第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系Selleck为您提供正确的澄清溶液配方）

% DMSO+ % + % Tween 80+ % ddH₂O

计算重置

计算结果:

工作液浓度： mg/ml；

DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，注：如该浓度超过该批次药物DMSO溶解度，请先联系Selleck）；

体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL ddH₂O，混匀澄清。

注意：1. 首先保证母液是澄清的；
2. 一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。

计算器

摩尔浓度计算器

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系，公式为:

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子量 (g/mol)

摩尔浓度计算公式

质量

浓度

体积

分子量
=

×

×

*在配置溶液时，请务必参考Selleck产品标签上、MSDS / COA（可在Selleck的产品页面获得）批次特异的分子量使用本工具。

稀释计算器

用本工具协助配置特定浓度的溶液，使用的计算公式为：

开始浓度 x 开始体积 = 最终浓度 x 最终体积

稀释公式

稀释公式一般简略地表示为: C1V1 = C2V2 ( 输入输出 )

C1

V1

C2

V2
×

=

×

在配置溶液时，请务必参考Selleck产品标签上、MSDS / COA（可在Selleck的产品页面获得）批次特异的分子量使用本工具。.

连续稀释计算器方程

连续稀释
初始浓度:
稀释倍数:

计算结果

C1=C0/X	C1:	LOG(C1):
C2=C1/X	C2:	LOG(C2):
C3=C2/X	C3:	LOG(C3):
C4=C3/X	C4:	LOG(C4):
C5=C4/X	C5:	LOG(C5):
C6=C5/X	C6:	LOG(C6):
C7=C6/X	C7:	LOG(C7):
C8=C7/X	C8:	LOG(C8):

分子量计算器

通过输入化合物的化学式来计算其分子量：

注：化学分子式大小写敏感。C10H16N2O2 c10h16n2o2

摩尔浓度计算器

质量	浓度	体积	分子量
=	×	×
计算

临床试验信息 (data from https://clinicaltrials.gov, updated on 2020-01-06)

NCT Number	Recruitment	interventions	Conditions	Sponsor/Collaborators	Start Date	Phases
NCT04606771	Recruiting	Drug: Osimertinib + Savolitinib\|Drug: Savolitinib + Placebo	Non-Small Cell Lung Cancer	AstraZeneca	September 28 2020	Phase 2
NCT03901053	Recruiting	Device: Reaktiv AFO\|Device: PhatBrace AFO	Foot Injuries and Disorders	Jason Wilken\|Minneapolis Veterans Affairs Medical Center\|Walter Reed National Military Medical Center\|Henry M. Jackson Foundation for the Advancement of Military Medicine\|Center for Veterans Research and Education\|University of Delaware\|Johns Hopkins Bloomberg School of Public Health\|University of Iowa	February 27 2020	Not Applicable
NCT03887650	Recruiting	Drug: Liposomal Bupivicaine 1.3%\|Drug: Bupivacaine 0.5%	Post-operative Pain\|Total Shoulder Arthroplasty\|Osteoarthritis of the Shoulder\|Pain Management	Hartford Hospital	January 14 2019	Phase 4

技术支持

在订购、运输、储存和使用我们的产品的任何阶段，您遇到的任何问题，均可以通过拨打我们的热线电话400-668-6834，或者技术支持邮箱tech@selleck.cn，直接联系到我们。我们会在24小时内尽快联系您。

操作手册

如果有其他问题，请给我们留言。

常见问题及建议解决方法

问题 1：
I would like to obtain the enantiomers of TSA, as separate chemicals: R-TSA and S-TSA. Do you have any ideas?
回答：
Our S1045 Trichostatin A (TSA) is R enantiomer.

HDAC Signaling Pathway Map

HDAC Inhibitors with Unique Features

选择性强的HDAC抑制剂

RGFP966 : HDAC3-selective, IC50=80 nM.
选择性强的HDAC抑制剂

Rocilinostat (ACY-1215) : HDAC5-selective, IC50=5 nM.
活性最强的HDAC抑制剂

Quisinostat (JNJ-26481585) : HDAC1, IC50=0.11 nM; HDAC2, IC50=0.33 nM.
FDA批准的HDAC抑制剂

Vorinostat (SAHA, MK0683) : Approved by FDA against cutaneous T cell lymphoma.
最新的HDAC抑制剂

RG2833 (RGFP109) ^New : Brain-penetrant HDAC inhibitor with IC50 of 60 nM and 50 nM for HDAC1 and HDAC3, respectively.

研究领域

产品类型

定制您的化合物库

Trichostatin A (TSA)

客户使用Selleck生产的Trichostatin A (TSA)发表文献166篇：

产品安全说明书

HDAC抑制剂选择性比较

生物活性

推荐的实验操作(此推荐来自于公开的文献所以Selleck并不保证其有效性)

参考文献

溶解度 (25°C)

化学数据 Download Trichostatin A (TSA) SDF

动物体内配方计算器 (澄清溶液)

计算器

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子量 (g/mol)

摩尔浓度计算公式

稀释计算器

开始浓度 x 开始体积 = 最终浓度 x 最终体积

稀释公式

连续稀释计算器方程

连续稀释

计算结果

分子量计算器

总分子量：g/mol

摩尔浓度计算器

临床试验信息 (data from https://clinicaltrials.gov, updated on 2020-01-06)

技术支持

常见问题及建议解决方法

HDAC Signaling Pathway Map

HDAC Inhibitors with Unique Features

相关HDAC产品